<SEC-DOCUMENT>0001638833-22-000002.txt : 20220110
<SEC-HEADER>0001638833-22-000002.hdr.sgml : 20220110
<ACCEPTANCE-DATETIME>20220110073719
ACCESSION NUMBER:		0001638833-22-000002
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20220105
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220110
DATE AS OF CHANGE:		20220110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Surgery Partners, Inc.
		CENTRAL INDEX KEY:			0001638833
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		IRS NUMBER:				473620923
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37576
		FILM NUMBER:		22519710

	BUSINESS ADDRESS:	
		STREET 1:		310 SEVEN SPRINGS WAY
		STREET 2:		SUITE 500
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
		BUSINESS PHONE:		615-234-5900

	MAIL ADDRESS:	
		STREET 1:		310 SEVEN SPRINGS WAY
		STREET 2:		SUITE 500
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sgry-20220105.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:bd7a204e-0152-4f82-a7d1-efb1ddd97c48,g:fcebee0a-c2fa-4092-a7ef-c6a9e47d2db4,d:30f906e4b2934213ab12e7cd86d32b99--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sgry-20220105</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV80L2ZyYWc6NWE2MWEyZjNhYWI4NDc1YmE3ZmFkODJkNzI4MTA4ZWEvdGFibGU6ODhhYzE4ZGI3ZWQ0NDE1Mjk3NzQxYjNlMTgyZjM0M2IvdGFibGVyYW5nZTo4OGFjMThkYjdlZDQ0MTUyOTc3NDFiM2UxODJmMzQzYl8yLTEtMS0xLTI4Mjc2_684c0856-021f-48dd-8b1d-5fbabdc337d3">0001638833</ix:nonNumeric><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV80L2ZyYWc6NWE2MWEyZjNhYWI4NDc1YmE3ZmFkODJkNzI4MTA4ZWEvdGFibGU6ODhhYzE4ZGI3ZWQ0NDE1Mjk3NzQxYjNlMTgyZjM0M2IvdGFibGVyYW5nZTo4OGFjMThkYjdlZDQ0MTUyOTc3NDFiM2UxODJmMzQzYl8zLTEtMS0xLTI4Mjc2_5a66b1eb-191c-4a58-97f5-dd378d171593">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV80L2ZyYWc6NWE2MWEyZjNhYWI4NDc1YmE3ZmFkODJkNzI4MTA4ZWEvdGFibGU6ODhhYzE4ZGI3ZWQ0NDE1Mjk3NzQxYjNlMTgyZjM0M2IvdGFibGVyYW5nZTo4OGFjMThkYjdlZDQ0MTUyOTc3NDFiM2UxODJmMzQzYl81LTEtMS0xLTI4Mjc2_77a25b4e-8e9d-4c83-9b52-cf3f418d4350">January 5, 2022</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sgry-20220105.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638833</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-05</xbrli:startDate><xbrli:endDate>2022-01-05</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i30f906e4b2934213ab12e7cd86d32b99_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Form <ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjEz_ff6f2fad-cc83-44c9-a01a-44d9db076963">8-K</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.638%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Date of Report (Date of earliest event reported):   <ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGFibGU6ZGU5NjRkMDdhMGY2NDBjZTg3NDg5MzFjMjBlNDg0NWMvdGFibGVyYW5nZTpkZTk2NGQwN2EwZjY0MGNlODc0ODkzMWMyMGU0ODQ1Y18wLTAtMS0xLTI4Mjc2L3RleHRyZWdpb246MjlhN2JhYTE0NTdmNDg2ODkyMWUyZGFkMzQwMjI4MjNfNTY_77a25b4e-8e9d-4c83-9b52-cf3f418d4350">January&#160;5, 2022</ix:nonNumeric></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGFibGU6ZGU5NjRkMDdhMGY2NDBjZTg3NDg5MzFjMjBlNDg0NWMvdGFibGVyYW5nZTpkZTk2NGQwN2EwZjY0MGNlODc0ODkzMWMyMGU0ODQ1Y18yLTAtMS0xLTI4Mjc2_b7a8a033-ff5f-4538-b2da-d32dbd70e141">Surgery Partners, Inc.</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Exact Name of Registrant as Specified in Charter)</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.500%"><tr><td style="width:1.0%"></td><td style="width:32.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGFibGU6M2IwNmZiMDVhYzZkNDZhNDhjNGI2YzU2YWY1M2Y4M2UvdGFibGVyYW5nZTozYjA2ZmIwNWFjNmQ0NmE0OGM0YjZjNTZhZjUzZjgzZV8wLTAtMS0xLTI4Mjc2_5ac6d288-9462-4e20-b0ee-f719d6346319">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGFibGU6M2IwNmZiMDVhYzZkNDZhNDhjNGI2YzU2YWY1M2Y4M2UvdGFibGVyYW5nZTozYjA2ZmIwNWFjNmQ0NmE0OGM0YjZjNTZhZjUzZjgzZV8wLTEtMS0xLTI4Mjc2_5310cb2a-80b1-46d9-b913-a123e228debc">001-37576</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGFibGU6M2IwNmZiMDVhYzZkNDZhNDhjNGI2YzU2YWY1M2Y4M2UvdGFibGVyYW5nZTozYjA2ZmIwNWFjNmQ0NmE0OGM0YjZjNTZhZjUzZjgzZV8wLTItMS0xLTI4Mjc2_d1ba2c25-e43d-4338-8247-d44cb8830ee0">47-3620923</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or Other Jurisdiction<br/>of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjE0_153d849c-cfe5-4f8f-923d-e98d598f1bab"><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjA1_b1d9205c-3bf1-4c17-9280-a640baa819f5">310 Seven Springs Way, Suite&#160;500</ix:nonNumeric></ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjAw_bbd0988f-b1e3-4367-8dea-0a8274344569"><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjIw_aa17f600-f3b2-491c-94bf-c35b7602c520">Brentwood</ix:nonNumeric></ix:nonNumeric>, <ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjAx_5142f7d9-a80a-4c74-822e-4f52ef7c859b">Tennessee</ix:nonNumeric> <ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjA2_116fbe64-1e9d-4adf-8e39-67e418af6b91">37027</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjE1_b692631b-9e57-4c9e-9de6-a1a32629aada">615</ix:nonNumeric>) <ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjIx_b271b592-e5cd-474a-a4ed-357aaac7cbf2">234-5900</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Former Name or Former Address, If Changed Since Last Report)</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjA3_b31dcba8-4100-464f-8ffa-716e03e4a71c">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjA4_2a6f8698-ff7e-41bf-b631-4e8dc447b419">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjAz_059618ca-bb9d-4128-b8fe-5639c3ae494f">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjA0_920e631c-2cf2-41d9-b26e-3cfe12205d67">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:9pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:33.164%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.167%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGFibGU6ZmE2MmZjYWNlYjYwNDQzZTllMjgyOGJjNTVhZWY3OGEvdGFibGVyYW5nZTpmYTYyZmNhY2ViNjA0NDNlOWUyODI4YmM1NWFlZjc4YV8xLTAtMS0xLTI4Mjc2_77851037-88a9-45b3-ab62-3701b26b2af2">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGFibGU6ZmE2MmZjYWNlYjYwNDQzZTllMjgyOGJjNTVhZWY3OGEvdGFibGVyYW5nZTpmYTYyZmNhY2ViNjA0NDNlOWUyODI4YmM1NWFlZjc4YV8xLTItMS0xLTI4Mjc2_866c88db-e925-401f-abb4-9faab8cc158f">SGRY</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGFibGU6ZmE2MmZjYWNlYjYwNDQzZTllMjgyOGJjNTVhZWY3OGEvdGFibGVyYW5nZTpmYTYyZmNhY2ViNjA0NDNlOWUyODI4YmM1NWFlZjc4YV8xLTQtMS0xLTI4Mjc2_b5e3fb72-c2f6-45a7-a6c1-34bc0b1072f4">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company     </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjIz_75fc7f1d-65c4-4d67-bb85-3cf688eef41f">&#9744;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Act.     </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:8pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i30f906e4b2934213ab12e7cd86d32b99_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 2.02  Results of Operations and Financial Condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Members of management of Surgery Partners, Inc. (the &#8220;Company&#8221;) will be meeting with investors on January 10, 2022, as part of the 40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Annual J.P. Morgan Healthcare Conference, including a virtual presentation at 5:15 p.m. (Eastern Time). Based on results through November 2021, the Company is re-affirming its 2021 Adjusted EBITDA guidance of $325 million to $330 million and its 2021 Revenue guidance of 19% to 21% over 2020 results. The Company completed the deployment of approximately $185 million of capital in three acquisitions in December 2021, at a weighted average multiple of approximately 8.5x 2022E Adjusted EBITDA and is re-affirming its preliminary 2022 Adjusted EBITDA guidance of at least $370 million.  This information is included in a Corporate Presentation that may be used for these meetings. The Corporate Presentation is available on the Company&#8217;s website at http://ir.surgerypartners.com/events-and-presentations/presentations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guidance for the fiscal year ended December 31, 2021 is based on results of the Company through November 2021 and is subject to quarter- and year-end adjustments in connection with the completion of customary financial closing procedures, including management&#8217;s review and finalization of the results for the full year 2021 and to accounting review procedures by the Company&#8217;s independent registered public accounting firm, which have not yet been performed. These customary closing procedures, along with December results, could cause actual results to differ materially from management&#8217;s guidance. Please also refer to Item 1A &#8220;Risk Factors&#8221; in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 and the Company&#8217;s Quarterly Reports on Form 10-Q for the quarters ended March 31, 2021, June 30, 2021 and September 30, 2021, and discussed from time to time in the Company&#8217;s reports filed with the Securities and Exchange Commission. You are cautioned not to rely on management&#8217;s guidance being achieved when making an investment decision in the Company&#8217;s securities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is a financial measure that has not been prepared in accordance with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;) and the Company&#8217;s definition and computation of this non-GAAP financial measure may vary from those used by other companies. This measure has limitations as an analytical tool and should not be considered isolation or as a substitute or alternative to net income or loss, operating income or loss, or any other measures of operating performance derived in accordance with GAAP. The Company defines the term &#8220;Adjusted EBITDA&#8221; as income before income taxes adjusted for net income attributable to non-controlling interests, depreciation and amortization, interest expense, net, equity-based compensation expense, transaction, integration and acquisition costs, loss on disposals and deconsolidations, net, impairment charges, litigation settlement and other litigation costs and certain other items that we do not believe are representative of our ongoing operations. The Company is unable to present a quantitative reconciliation of Adjusted EBITDA to net income/loss for the periods presented because management cannot reasonably predict with sufficient reliability all of the necessary components of net income/loss for the periods presented. The determination of the amounts that are excluded from non-GAAP financial measure is a matter of management judgment and depends upon, among other factors, the nature of the underlying expense or income amounts.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in this Current Report is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933 or the Exchange Act.</span></div><div id="i30f906e4b2934213ab12e7cd86d32b99_10"></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.02  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Appointment of David T. Doherty as Executive Vice President and Chief Financial Officer</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 10, 2022, the Company announced the appointment of David T. Doherty to serve as Executive Vice President and Chief Financial Officer of the Company, effective as of February 1, 2022. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Doherty, 49, joined Surgery Partners in April of 2018 and assumed the role of Senior Vice President, Corporate Finance and Controller in August of 2018, with oversight of investor relations, financial planning &amp; analysis, internal audit, tax and controllership.  Prior to Surgery Partners, Mr. Doherty spent 15 years at Aetna, Inc. in a variety of roles including leadership roles for internal audit, planning, SEC reporting and controllership and as chief of staff to the Chief Financial Officer.  He began his career with Arthur Andersen, where he earned his CPA.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the press release announcing Mr. Doherty&#8217;s appointment as Executive Vice President and Chief Financial Officer has been filed as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 99.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to this Current Report on Form 8-K and is incorporated herein by reference.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employment Agreement with David T. Doherty</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 7, 2022, the Company entered into an employment agreement with Mr. Doherty (the &#8220;Employment Agreement&#8221;). Pursuant to the terms of the Employment Agreement, Mr. Doherty is entitled to receive an annual base salary of $515,000, subject to adjustment at the discretion of the Board of Directors of the Company (the &#8220;Board&#8221;) or its designee. In addition, Mr. Doherty is eligible to earn an annual bonus with a target amount equal to 75% of Mr. Doherty&#8217;s base salary, with the amount of such bonus to be determined by the Board or its designee based on the achievement of performance goals </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">established by the Board or its designee. The Employment Agreement entitles Mr. Doherty to participate in Company employee benefit programs for which senior executives of the Company are generally eligible, subject to the eligibility and participation requirements thereof (the &#8220;Welfare Benefits&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employment Agreement also provides that Mr. Doherty will be granted, on or as soon as reasonably practicable following commencement of his role as Executive Vice President and Chief Financial Officer, a restricted stock award of shares common stock of the Company, par value $0.01 per share (the &#8220;Common Stock&#8221;), worth $200,000 on the date of grant (the &#8220;Restricted Stock Award&#8221;), which is subject in all respects to the Company&#8217;s 2015 Omnibus Incentive Plan, as amended and restated effective January 1, 2020, as amended (a copy of which was filed as Exhibit 10.17(a) to the Company&#8217;s Annual Report on Form 10-K filed on March 10, 2021) (the &#8220;Incentive Plan&#8221;) and agreements under which such awards pursuant to the plan are granted. The Restricted Stock Award will vest as to one-third of the award on each of the first three anniversaries of the date of grant, generally subject to continued employment on each vesting date and certain annual limits under the Incentive Plan; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Doherty will also be eligible for annual equity grants under the Incentive Plan with an annual target amount of $800,000, subject to approval of the Board (or an authorized committee thereof) in such forms determined by the Board or its designee in its discretion.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employment Agreement may be terminated (i) by Mr. Doherty upon 30 days&#8217; advance written notice for any or no reason, (ii) by Mr. Doherty for &#8220;Good Reason,&#8221; (iii) upon Mr. Doherty&#8217;s death or &#8220;Incapacity&#8221; or (iv) by the Company at any time for &#8220;Cause&#8221; or without Cause.  If Mr. Doherty&#8217;s employment is terminated by the Company without &#8220;Cause&#8221; or if he resigns for &#8220;Good Reason,&#8221; Mr. Doherty will be entitled to receive, subject to the execution of a release of claims and continued compliance with the restrictive covenants contained in the Employment Agreement, (i) 12 months base salary payable in the form of salary continuation over the 12-month period following the date of termination, (ii) continuation of the Welfare Benefits for twelve (12) months to the extent permissible under the terms of the relevant benefit plans at the same cost to Mr. Doherty as if Mr. Doherty were an active employee of the Company; (iii) any then-current annual bonus amount payable to Mr. Doherty within 3 months after the end of the applicable year (to the extent not previously paid), paid in a lump sum at the time that bonuses are regularly paid to employees; (iv) with respect to the portion of each restricted stock award held by Mr. Doherty as of date on which the Employment Agreement is terminated that is subject to time-based vesting (the &#8220;Time-Based RSA&#8221;), accelerated vesting of the Time-Based RSA to the vesting event next following the date on which the Employment Agreement is terminated; (v) with respect to the portion of each performance stock unit award held by Mr. Doherty as of the date on which the Employment Agreement is terminated that has been converted into &#8220;earned shares&#8221; (the &#8220;Earned PSUs&#8221;), accelerated vesting of the Earned PSUs to the vesting event next following the date on which the Employment Agreement is terminated; and (vi) with respect to each performance stock unit award issued after December 31, 2021, held by Mr. Doherty as of the date on which the Employment Agreement ends that have not been converted to Earned PSUs, Mr. Doherty&#8217;s rights under the award will be fully vested based on the number of shares that would be earned under the award based on performance measured through the end of Employment Agreement. If Mr. Doherty&#8217;s employment is terminated by the Company without &#8220;Cause&#8221; or by Mr. Doherty for &#8220;Good Reason&#8221;, in each case within 90 days prior to or 12 months following a change in control, Mr. Doherty is entitled to be paid the above severance benefits in a single lump-sum payment no later than 30 days following such termination of employment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Employment Agreement, Mr. Doherty is bound by certain restrictive covenants, including non-competition, interference with relationships, and non-solicitation restrictions for a period of 12 months following the termination of his employment. The Employment Agreement includes certain other customary terms, including with respect to protection of confidential information and documents, assignment of intellectual property rights and reimbursement of business expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Doherty has also entered into the Company&#8217;s standard form of indemnification agreement, a copy of which is filed as Exhibit 10.14 to Amendment No. 1 to the Company&#8217;s Registration Statement on Form S-1 filed on September 14, 2015.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the Employment Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Employment Agreement, which is incorporated into this Item 5.02 by reference to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 10.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Current Report on Form 8-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Resignation of Thomas F. Cowhey</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 5, 2022, Thomas F. Cowhey, the Executive Vice President and Chief Financial Officer of the Company, notified the Board of Directors of the Company of his intention to resign from his current role.  Mr. Cowhey and the Company agreed that Mr. Cowhey&#8217;s resignation from his current role would be effective January 31, 2022, but Mr. Cowhey has agreed to remain with the Company through the end of February 2022. In recognition of his service to the Company, the Board agreed to the vesting of all of Mr. Cowhey&#8217;s outstanding, unvested PSUs and restricted stock awards that are set to vest in March 2022, which vesting will occur in accordance with their terms in March 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i30f906e4b2934213ab12e7cd86d32b99_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01  Financial Statements and Exhibits.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.252%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a20220110dohertyexecutivee.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a20220110dohertyexecutivee.htm">Employment Agreement, dated January 7, 2022, by and between Surgery Partners, Inc. and David T. Doherty</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a20220110ex991prguidancean.htm">99.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a20220110ex991prguidancean.htm">Press release dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a20220110ex991prguidancean.htm">J</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a20220110ex991prguidancean.htm">anuary 10, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i30f906e4b2934213ab12e7cd86d32b99_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:8pt;margin-top:5pt;padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:249.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:222.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SURGERY PARTNERS,&#160;INC.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:45pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/  Jennifer B. Baldock</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer B. Baldock</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Administrative Officer</span></div></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date:  January 10, 2022</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a20220110dohertyexecutivee.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i69458cd374cd43fe98aaaa39d0acf2b1_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EMPLOYMENT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">THIS EMPLOYMENT AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is hereby entered into effective as of January 7, 2022 (the &#8220;Effective Date&#8221;), between Surgery Partners, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and David Doherty (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Company shall employ Executive, and Executive hereby accepts continued employment with the Company, upon the terms and conditions set forth in this Agreement for the period beginning on February 1, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Commencement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and ending on the Termination Date, as provided for in Section 4 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Employment Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Position and Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.7pt">During the Employment Period, Executive shall serve as Executive Vice President, Chief Financial Officer.  Executive shall have such responsibilities, duties and authorities, and will render such services for the Company and its Subsidiaries or Affiliates as the Board of Directors of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) may from time to time direct.  Executive will devote his&#47;her best efforts, energies and abilities and his&#47;her full business time, skill and attention to the business and affairs of the Company and its Subsidiaries, and shall perform his&#47;her duties and responsibilities to the best of his&#47;her ability, in a diligent, trustworthy, businesslike and efficient manner for the purpose of advancing the businesses of Company and its Subsidiaries.  Executive acknowledges that his&#47;her duties and responsibilities will require his&#47;her full time business efforts and agrees that during the Employment Period he&#47;she will not engage in any other business activity or have any business pursuits that interfere with Executive&#8217;s duties and responsibilities under this Agreement or are competitive with the businesses of the Company.  Notwithstanding the foregoing, Executive shall be permitted to devote a reasonable amount of time and effort to (i) providing service to, or serving on governing boards of, civic and charitable organizations, and (ii) personally investing and managing personal and family investments in real estate and in any corporation, partnership or other entity&#59; but in each case, only to the extent that any of the activities described in clauses (i) or (ii), individually or as a whole, do not (A) require or involve the active participation of Executive in the management of any corporation, partnership or other entity or interfere with the execution of Executive&#8217;s duties hereunder, or (B) otherwise violate any provision of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt">For purposes of this Agreement, (i) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any corporation or other entity (A) of which the securities or other ownership interests having the voting power to elect a majority of the board of directors or other governing body are, at the time of determination, owned by the Company, directly or through one or more subsidiaries or (B) to which the Company or any of its Affiliates provide management services, and (ii) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of an entity means any other person or entity, directly or indirectly controlling, controlled by or under common control with an entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Compensation and Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.7pt">During the Employment Period, Executive&#8217;s base salary shall be $515,000 per annum, payable by the Company in regular installments in accordance with the Company&#8217;s general payroll practices, less taxes and other applicable withholdings, and subject to review and adjustment from time to time by the Board or the Compensation Committee thereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), in either case, in its discretion (as modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt">In addition, during the Employment Period, Executive shall be entitled to participate in all of the Company&#8217;s benefit programs for which employees of the Company are generally eligible, subject to the eligibility and participation requirements thereof, including, but not limited to, the following&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.69pt">medical, dental, vision, life and disability insurance, as is generally provided to other employees of the Company&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt">eligibility for vacation time in accordance with the policies of the Company as from time to time in effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.7pt">During the Employment Period, the Company shall reimburse Executive for all reasonable out-of-pocket expenses incurred by his&#47;her in the course of performing his&#47;her duties and responsibilities under this Agreement which are consistent with the Company&#8217;s policies in effect from time to time with respect to travel, entertainment and other business expenses, subject to the Company&#8217;s requirements with respect to reporting and documentation of such expenses. Executive&#8217;s right to payment or reimbursement for business expenses hereunder will be subject to the following additional rules&#58; (i) no reimbursement of any expense shall affect Executive&#8217;s right to reimbursement of any other expense in any other taxable year&#59; (ii) the amount of expenses eligible for payment or reimbursement during any calendar year will not affect the expenses eligible for payment or reimbursement in any other taxable year&#59; (iii) payment or reimbursement will be made not later than December 31 of the calendar year following the calendar year in which the expense was incurred or paid, and (iv) the right to payment or reimbursement is not subject to liquidation or exchange for any other benefit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt">In addition to the Base Salary, Executive will be eligible to receive an annual bonus of seventy-five percent (75%) of the Base Salary, with the actual amount of any such bonus being determined by the Board or the Committee, in either case, in its discretion, based on the achievement of performance goals established annually by the Board or the Committee, as applicable.  Any annual bonus payable under this Section 3(d) will be paid no later than March 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> following the close of the year for which the bonus is earned.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.7pt">Executive shall be eligible to participate in the Surgery Partners, Inc. 2015 Omnibus Incentive Plan (as amended from time to time, (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Equity Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) on terms and conditions set forth therein and in the relevant award agreement unless specifically stated otherwise in this Agreement. Executive will be eligible for annual equity grants under the Equity Plan. Initially, the targeted equity grant will be $800,000, subject to approval of the Board (or an authorized committee thereof), in such forms as determined by the Board or its designee in its discretion.  In addition, subject to approval by the Committee or its designee, as soon as reasonably practical following the Commencement Date, the Company shall grant under the Equity Plan to the Executive equity with an aggregate value of $200,000 as follows&#58; (1) a restricted stock award that becomes vested in three equal annual installments following the grant date&#59; and (2) a performance stock unit award that becomes earned and vested based on performance criteria specified in the award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.03pt">All amounts payable to Executive hereunder shall be subject to all required withholdings by the Company.  If additional guidance is issued under, or modifications are made to, Section 409A of the Internal Revenue Code of the Internal Revenue Code and the regulations and other interpretive guidance issued thereunder (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), or any other law affecting payments to be made under this Agreement, Executive agrees that the Company may take such reasonable actions and adopt such reasonable amendments as the Company believes are necessary to ensure continued compliance with the Internal Revenue Code, including Section 409A.  However, the Company does not hereby or otherwise represent or warrant that any payments hereunder are or will be in compliance with Section 409A, and Executive shall be responsible for obtaining his&#47;her own tax advice with regard to such matters.  </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-2-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Termination by Executive or the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Employment Period (i) shall terminate upon Executive&#8217;s resignation with Good Reason (as defined below) or without Good Reason, death or Incapacity (as defined below) or (ii) may be terminated by the Company at any time for Cause (as defined below) or without Cause.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean without the written consent of Executive&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.69pt">without the express written consent of Executive, a material diminution of his&#47;her position, duties, responsibilities, and status with the Company as in effect as of the Commencement Date or a material reduction of Executive&#8217;s resources as in effect on the Commencement Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt">a material reduction in Executive&#8217;s Base Salary or annual bonus target percentage&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.03pt">a material reduction in the level of benefits available or awarded to Executive, other than any reduction in connection with a Company-wide reduction applicable generally to similarly situated executive officers of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.69pt">within twelve months of a Change in Control (as defined herein), a material increase in Executive&#8217;s core functional responsibilities with a corresponding material change in Executive&#8217;s core functional role without a corresponding increase in compensation, provided, however, the addition of additional facilities or territories to Executive&#8217;s oversight responsibilities or other ordinary course growth of the Company or any of its Subsidiaries or Affiliates shall not be a material increase in Executive&#8217;s core functional responsibilities&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt">a relocation by the Company of Executive&#8217;s primary employment location to a location which is more than 50 miles from Executive&#8217;s primary employment location on the date hereof&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.69pt">a material breach by the Company of the terms of this Agreement&#59; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">but only if (x) Executive notifies the Company in writing within 90 days after the initial existence or occurrence of any of these conditions which notice describes in reasonable detail the basis for Executive&#8217;s belief that Good Reason exists and that Executive intends to resign for Good Reason and the Company, within 30 days after receipt of such notice, either fails to cure the condition or delivers a written notice to Executive that the Company intends not to cure such condition and (y) Executive actually resigns prior to 15 days after the earlier to occur of either the end of such 30-day cure period or delivery of such written notice by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incapacity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; as used herein shall mean that Executive is unable to perform, with or without reasonable accommodation, by reason of physical or mental incapacity, the essential duties, responsibilities and functions of his&#47;her position.  A medical examination by a physician selected by the Company to whom Executive or his&#47;her duly appointed guardian, if any, has no reasonable objection shall determine, according to the facts then available, whether and when Incapacity has occurred.  Such determination shall not be arbitrary or unreasonable, and shall be final and binding on the parties hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; as used herein means the occurrence of any of the following events&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.69pt">a material breach by Executive of any of the terms and conditions of this Agreement&#59; provided that, if curable, Executive shall have a reasonable period of time (which in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">no event shall exceed 45 days) during which to cure such material breach following the date on which Executive receives the Company&#8217;s written notice of such material breach&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt">Executive&#8217;s reporting to work (A) intoxicated (other than Executive&#8217;s reasonable use of alcohol in connection with business entertainment, provided, that such use of alcohol does not cause the Company or any of its Subsidiaries or Affiliates substantial public disgrace or disrepute or economic harm) or (B) under the influence of illegal drugs&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.03pt">Executive&#8217;s use of illegal drugs (whether or not at the workplace) or other conduct causing the Company or any of its Subsidiaries or Affiliates substantial public disgrace or disrepute or economic harm&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.69pt">breach of fiduciary duty, gross negligence or willful misconduct with respect to the Company or any of its Subsidiaries or Affiliates&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt">chronic absenteeism, which shall be deemed to have occurred if Executive has at least ten absences unrelated to paid time off, disability or illness in any ten week period&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.69pt">Executive&#8217;s material failure or willful refusal to substantially perform his&#47;her duties, responsibilities and functions&#59; provided that, if curable, Executive shall have a reasonable period of time (which in no event shall exceed 45 days) during which to cure such failure following the date on which Executive receives the Company&#8217;s written notice of such failure&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.36pt">Executive&#8217;s failure to comply with any of the Company&#8217;s or any of its Subsidiaries&#8217; written guidelines or procedures promulgated by the Company or any such Subsidiary and furnished to Executive, including, without limitation, any guidelines or procedures relating to marketing or community relations&#59; provided that, if curable, Executive shall have a reasonable period of time (which in no event shall exceed 45 days) during which to cure such failure following the date on which Executive receives the Company&#8217;s written notice of such failure&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.03pt">Executive has committed an act or acts constituting a felony or any other act or omission involving theft, dishonesty or fraud against the Company or any of its Subsidiaries or any of their respective customers or suppliers or other business relationships.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.7pt">A &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall be deemed to have occurred upon any of the following events, provided that, to the extent required by Section 409A, such events would also qualify as a &#8220;change in control event&#8221; under Treas. Reg. &#167;1.409A-3(i)(5)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.69pt">Upon the closing of a reorganization, merger, share exchange or consolidation, other than a reorganization, merger, share exchange or consolidation with respect to which those persons who were the beneficial owners, immediately prior to such reorganization, merger, share exchange or consolidation, of outstanding securities of the Company ordinarily having the right to vote in the election of directors own, immediately after the closing of such transaction, more than 51% of the outstanding securities of the resulting corporation ordinarily having the right to vote in the election of directors&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt">Upon approval by the stockholders of a complete liquidation and dissolution of the Company or the sale or other disposition of all or substantially all of the assets of the Company other than to a Subsidiary or Affiliate.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Termination by Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Executive has the right to terminate his&#47;her employment under this Agreement at any time, for any or no reason, but only after giving the Company (i) 30 days prior written notice with respect to any termination without Good Reason or (ii) the number of days prior </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-4-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">written notice set forth in the last sentence of Section 4(b) with respect to any termination with Good Reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Compensation after Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.69pt">If the Employment Period is terminated pursuant to Executive&#8217;s resignation without Good Reason, death or Incapacity, Executive shall only be entitled to receive his&#47;her Base Salary through the date of termination and shall not be entitled to any other salary, bonus, compensation or benefits from the Company or its Subsidiaries, except as may be required by applicable law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt">If the Employment Period is terminated by the Company for Cause, Executive shall only be entitled to his&#47;her Base Salary through the date of termination and shall not be entitled to any other salary, bonus, compensation or benefits from the Company or its Subsidiaries, except as may be required by applicable law.  In addition, in such event, Executive shall automatically forfeit any rights to any unvested equity owned by Executive in the Company or any Subsidiary.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.03pt">If the Employment Period is terminated by the Company without Cause or by Executive for Good Reason, then subject to the conditions described in Section 4(g)(v) below, Executive shall be entitled to receive as severance compensation the following (collectively, &#8220;Severance Pay&#8221;)&#58; (A) an amount equal to twelve (12) months of Executive&#8217;s then-current annual Base Salary, payable in regular installments beginning within 30 days following the Termination Date in accordance with the Company&#8217;s general payroll practices for salaried employees&#59; (B) continuation of the welfare benefits described in Section 3(b) for twelve (12) months to the extent permissible under the terms of the relevant benefit plans at the same cost to Executive as if Executive were an active employee of the Company&#59; (C) the Bonus payable to Executive within 3 months after the end of the applicable year (to the extent not previously paid), paid in a lump sum at the time that bonuses are regularly paid to employees&#59; (D) with respect to the portion of each restricted stock award held by Executive as of date on which the Employment Period is terminated that is subject to time-based vesting (the &#8220;Time-Based RSA&#8221;), accelerated vesting of the Time-Based RSA to the vesting event next following the date on which the Employment Period is terminated&#59; and (E) with respect to the portion of each performance stock unit award held by the Executive as of the date on which the Employment Period is terminated that has been converted into &#8220;earned shares&#8221; (the &#8220;Earned PSUs&#8221;), accelerated vesting of the Earned PSUs to the vesting event next following the date on which the Employment Period is terminated&#59; and (F) with respect to each performance stock unit award issued after December 31, 2021, held by the executive as of the date on which the Employment Period ends that have not been converted to Earned PSUs, the Executive&#8217;s rights under the award will be fully vested based on the number of shares that would be earned under the award based on performance measured through the end of Employment Period.  For purposes of this Section 4(g), &#8220;Bonus&#8221; shall mean an amount equal to Executive&#8217;s then-current annual Base Salary, multiplied by the percentage contained in Section 3(d) hereof. For the avoidance of doubt, the unvested portion of any restricted stock awards and performance share unit awards held by Executive as of the date on which the Employment Period ends (after giving effect to the acceleration provisions set forth in subsections (D), (E) and (F) herein and the terms and conditions of the applicable award agreements and the Surgery Partners, Inc. 2015 Omnibus Incentive Plan (as amended from time to time)) shall be forfeited and of no further force and effect.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.69pt">If, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">within 90 days prior to or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12 months following a Change in Control, either (A) the Company terminates the employment of Executive hereunder without Cause under Section 4(a) above, or (B) Executive terminates his&#47;her employment for Good Reason under Section 4(b) above, then, in lieu of any other compensation that may be specified in this Agreement, the Company will pay Executive the Severance Pay in a single lump-sum payment </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-5-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">not later than 30 days after termination.  If any payment obligation under this Section 4(g) arises, no compensation received from other employment (or otherwise) will reduce the Company&#8217;s obligation to make the payment(s) described in this paragraph.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt">Notwithstanding Sections 4(g)(iii) or (iv), Executive&#8217;s right to receive Severance Pay hereunder is conditioned upon&#58; (A) Executive executing, and not revoking, a written separation agreement and general release of all claims against the Company, its Subsidiaries and Affiliates and their respective managers, directors, officers, shareholders, members, representatives, agents, attorneys, predecessors, successors and assigns (other than a claim for the severance payments described in Section 4(g)(iii) or (iv) and Executive&#8217;s rights to future distributions and payments related to the continued ownership of any equity securities in the Company that Executive will continue to own after such termination), in form and substance acceptable to the Company, which shall among other things, contain a general release by Executive of all claims arising out of his&#47;her employment and termination of employment by the Company (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Release Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) within 30 days of Executive&#8217;s Termination Date&#59; and (B) Executive&#8217;s material compliance with all of his&#47;her obligations which survive termination of this Agreement.  The Severance Pay is intended to be in lieu of all other payments to which Executive might otherwise be entitled in respect of his&#47;her termination without Cause or resignation with Good Reason.  The Company and its Subsidiaries and Affiliates shall have no further obligations hereunder or otherwise with respect to Executive&#8217;s employment from and after the date of termination of employment with the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and the Company and its Subsidiaries and Affiliates shall continue to have all other rights available hereunder (including without limitation, all rights hereunder at law or in equity).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.69pt">Notwithstanding the foregoing, the Release Agreement (x) shall not require the release of Executive&#8217;s rights arising from the express terms of this Agreement or any applicable award agreement that are associated with a termination of employment&#59; (y) shall not impose any postemployment restrictions other than those set forth in this Agreement, and (z) shall take into account and preserve Executive&#8217;s rights in the event that a Change in Control occurs within 90 days after termination of employment (or such longer tail period as may be provided by any agreement between Executive and the Company).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.36pt">Except as otherwise expressly provided herein, all of Executive&#8217;s rights to salary, bonuses, benefits and other compensation hereunder which might otherwise accrue or become payable after the termination of the Employment Period shall cease upon such termination, other than those expressly required under applicable law (such as COBRA).  All amounts payable to Executive as severance hereunder shall be subject to all required withholdings by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Company may offset any amount Executive owes the Company or its Subsidiaries or Affiliates against any amount they or their Subsidiaries or Affiliates owe Executive hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Confidential Information.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Other than in the performance of his&#47;her duties hereunder, during the Restrictive Period (as defined below) and thereafter, Executive shall keep secret and retain in strictest confidence, and shall not, without the prior written consent of the Company, furnish, make available or disclose to any third party or use for the benefit of himself or any third party, any Confidential Information.  As used in this Agreement, &#8220;Confidential Information&#8221; shall mean any information relating to the business or affairs of the Company or any of its Subsidiaries or Affiliates or the Business, including but not limited to any technical or non-technical data, formulae, compilations, programs, devices, methods, techniques, designs, processes, procedures, improvements, models, manuals, financial data, acquisition strategies and information, information relating to operating procedures and marketing strategies, and any other proprietary information used by the Company or any of its Subsidiaries or Affiliates in connection with the Business, irrespective of its form&#59; provided, however, that Confidential Information shall not include any information which is in the public domain or becomes known in the industry, in each case through no wrongful act on the part of Executive.  Executive </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-6-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">acknowledges that the Confidential Information is vital, sensitive, confidential and proprietary to the Company and its Subsidiaries and Affiliates.  Executive will immediately notify the Company of any unauthorized possession, use, disclosure, copying, removal or destruction, or attempt thereof, of any Confidential Information by anyone of which Executive becomes aware and of all details thereof.  Executive shall take all reasonably appropriate steps to safeguard Confidential Information and to protect it against disclosure, misuse, espionage, loss and theft.  Executive shall deliver to the Company at the termination or expiration of the Employment Period, or at any other time the Company may request, all memoranda, notes, plans, records, reports, computer tapes, computers, printouts and software and other documents and data (and copies thereof) embodying or relating to the Confidential Information, Inventions and Discoveries (as defined below) or the business of the Company or any of its Subsidiaries or Affiliates which Executive may then possess or have under his&#47;her control.  Nothing in this Agreement limits, restricts or in any other way affects Executive&#8217;s communicating with any governmental agency or entity, or communicating with any official or staff person of a governmental agency or entity, concerning matters relevant to the governmental agency or entity, or requires Executive to provide notice to the Company of the same.  Executive cannot be held criminally or civilly liable under any federal or state trade secret law for disclosing a trade secret (1) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, solely for the purpose of reporting or investigating a suspended violation of law, or (2) in a compliant or other document filed under seal in a lawsuit or other proceeding.  Notwithstanding this immunity from liability, Executive may be held liable if Executive unlawfully accesses trade secrets by unauthorized means.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; as used herein means the business of owning, operating, developing and&#47;or managing, or providing management or administrative services to, (a) ambulatory surgery centers anywhere in the United States or (b) physician-owned surgical hospitals within a 50 mile radius of any hospital that is owned, operated, developed or managed by the Company or any Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Inventions and Discoveries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.7pt">Executive understands and agrees that all inventions, discoveries, ideas, improvements, whether patentable, copyrightable or not, pertaining to the Business or relating to Company&#8217;s or any of its Subsidiaries&#8217; or Affiliates&#8217; actual or demonstrably anticipated research, development or inventions (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Inventions and Discoveries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) that result from any work performed by Executive solely or jointly with others for the Company or any of its Subsidiaries or Affiliates which Executive, solely or jointly with others, conceives, develops, or reduces to practice during the course of Executive&#8217;s employment with the Company or any of its Subsidiaries, are the sole and exclusive property of the Company.  Executive will promptly disclose all such matters to the Company and will assist the Company in obtaining legal protection for Inventions and Discoveries.  Executive hereby agrees on behalf of himself, his&#47;her executors, legal representatives and assignees that he&#47;she will assign, transfer and convey to the Company, its successors and assigns the Inventions and Discoveries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt">THE COMPANY AND EXECUTIVE ACKNOWLEDGE AND AGREE THAT SECTION 6(a) SHALL NOT APPLY TO AN INVENTION OF EXECUTIVE FOR WHICH NO EQUIPMENT, SUPPLIES, FACILITY OR TRADE SECRET INFORMATION OF THE COMPANY OR ANY OF ITS SUBSIDIARIES WAS USED AND WHICH WAS DEVELOPED ENTIRELY ON EXECUTIVE&#8217;S OWN TIME, UNLESS (A) THE INVENTION RELATED (I) TO THE BUSINESS OF THE COMPANY OR ANY OF ITS SUBSIDIARIES OR AFFILIATES OR (II) TO THE COMPANY&#8217;S OR ANY OF ITS SUBSIDIARIES&#8217; OR AFFILIATES&#8217; ACTUAL OR DEMONSTRABLY ANTICIPATED RESEARCH OR DEVELOPMENT, OR (B) THE INVENTION RESULTS FROM ANY WORK PERFORMED BY EXECUTIVE FOR THE COMPANY OR ANY OF ITS SUBSIDIARIES OR AFFILIATES.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.7pt">EXECUTIVE ACKNOWLEDGES THAT HE&#47;SHE HAS READ THIS SECTION 6 AND FULLY UNDERSTANDS THE LIMITATIONS WHICH IT IMPOSES UPON HIM AND HAS RECEIVED A DUPLICATE COPY OF THIS AGREEMENT FOR HIS&#47;HER RECORDS.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-7-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Executive acknowledges that in the course of his&#47;her employment with the Company or any of its Subsidiaries or Affiliates, or their predecessors or successors, he&#47;she has been and will be given access to and has and will become familiar with their trade secrets and with other Confidential Information and that his&#47;her services have been and shall be of special, unique and extraordinary value to the Company and its Subsidiaries or Affiliates.  Therefore, and in further consideration of the compensation to be paid to Executive hereunder and in connection with his&#47;her employment, and to protect the Company&#8217;s and its Subsidiaries&#8217; and Affiliates&#8217; Confidential Information, business interests and goodwill&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Non-compete</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Executive hereby agrees that for a period commencing on the date hereof and ending on the Termination Date, and thereafter, through the period ending twelve (12) months after the Termination Date (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restrictive Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), he&#47;she shall not, directly or indirectly, as employee, agent, consultant, stockholder, director, co-partner or in any other individual or representative capacity, own, operate, manage, control, engage in, invest in or participate in any manner in, act as a consultant or advisor to, render services for (alone or in association with any person, firm, corporation or entity), or otherwise assist any person or entity (other than the Company and its Subsidiaries) that engages in or owns, invests in, operates, manages or controls any venture or enterprise that directly or indirectly engages or is actively developing or attempting to develop in any element of the Business anywhere within a 50-mile radius of the Nashville, Tennessee metropolitan area or within a 50-mile radius of any area (or in the event such area is a major city, the metropolitan area relating to such city) in which the Company or any of its Subsidiaries on the Termination Date actively engages or is actively developing or attempting to develop in any element of the Business (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Territory</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; provided, however, that nothing contained herein shall be construed to prevent Executive from investing in the stock of any competing corporation listed on a national securities exchange or traded in the over-the-counter market, but only if Executive is not involved in the business of said corporation and if Executive and his&#47;her associates (as such term is defined in Regulation 14(A) promulgated under the Securities Exchange Act of 1934, as in effect on the date hereof), collectively, do not own more than an aggregate of 3% of the stock of such corporation.  With respect to the Territory, Executive specifically acknowledges that the Company and its Subsidiaries intend to expand the Business into and throughout the United States.  Notwithstanding the foregoing, the activity proscribed by this Section 7(a) shall not constitute a violation of this Section 7(a) where performed for (x) an entity where no more than a de minimis amount of revenue is derived from a business that is competitive with the business of the Company or any of its Affiliates&#59; or (y) an entity that derives no more than $100 million in revenue from one or more divisions, departments or segments, in the aggregate, that are engaged in any business competitive with the business of the Company or any of its Affiliates&#59; provided, that in either case, you are not responsible for (and do not engage or participate in) the day-to-day management, oversight or supervision of such business and provided you do not have direct supervision over the individual or individuals who are so responsible for such day-to-day management, oversight or supervision.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Interference with Relationships</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Without limiting the generality of the provisions of Section 7(a) hereof, Executive hereby agrees that, for a period commencing on the Commencement Date and ending on the Termination Date, and thereafter, through the period ending twelve (12) months after the Termination Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Solicit Restrictive Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), he&#47;she will not, directly or indirectly, as employee, agent, consultant, stockholder, director, partner or in any other individual or representative capacity, (i) solicit or encourage, or participate in any business which solicits or encourages (A) any person, firm, corporation or other entity which has executed, or proposes to execute, a management services agreement or other services agreement with the Company or any of its Subsidiaries at any time during the term of this Agreement, or any successor in interest to any such person, firm, corporation or other entity, for the purpose of securing business or contracts related to any element of the Business, or (B) any present customer or patient of the Company or any of its Subsidiaries or any of their Affiliated Practices to terminate or otherwise alter his, her or its relationship with the Company or any of its Subsidiaries or such Affiliated Practice&#59; provided, however, that nothing contained herein shall be construed to prohibit or restrict Executive from soliciting business from any such parties on behalf of the Company or any of its Subsidiaries in performance of his&#47;her duties as an employee of the Company </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-8-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">required under and as specifically contemplated by Section 2 above or (ii) divert, entice away, solicit or encourage, or attempt to divert, entice away, solicit or encourage, any physician who utilizes or has invested in an Affiliated Practice to become an owner, investor or user of another practice or facility that is not an Affiliated Practice or approach any such physician for any of the foregoing purposes or authorize or assist in the taking of any such action by any third party.  In addition, at all times from and after the Termination Date, Executive shall not contact or communicate in any manner with any of Company&#8217;s, or any of its Subsidiaries&#8217; or Affiliates&#8217; suppliers or vendors, or any other third party providing services to the Company or any of its Subsidiaries, regarding the Company or any of its Subsidiaries or any Company- or any such Subsidiary-related matter (which suppliers, vendors or third party service providers will include, without limitation, any third party with whom the Company or any of its Subsidiaries was, during the term of Executive&#8217;s employment with the Company or any of its Subsidiaries, contemplating engaging, or negotiating with, for the future provision of products or services).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Provided, however, that these restrictions shall apply (x) only with respect to those persons who are or have been a business partner of the Company or any of its Affiliates at any time within the immediately preceding two (2)-year period or whose business has been solicited on behalf of the Company or any of the Affiliates by any of their officers, employees or agents within such two (2)-year period, other than by form letter, blanket mailing or published advertisement, and (y) only if Executive has performed work for such person during his employment with the Company or one of its Affiliates or been introduced to, or otherwise had contact with, such person as a result of his employment or other associations with the Company or one of its Affiliates or have had access to Confidential Information which would assist in his solicitation of such person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Non-solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Other than in the performance of his&#47;her duties hereunder, during the Non-Solicit Restrictive Period, Executive shall not, directly or indirectly, as employee, agent, consultant, stockholder, director, co partner or in any other individual or representative capacity, employ, recruit or solicit for employment or engagement, any person who is employed or engaged by the Company or any of its Subsidiaries or any of its Affiliated Practices during the Non- Solicit Restrictive Period, or otherwise seek to influence or alter any such person&#8217;s relationship with any of the Affiliated Practices, the Company or any of its Subsidiaries&#59; provided, however that responses to a general solicitation (such as an internet or newspaper solicitation) that are not targeted towards any particular person shall not be deemed to be a violation of the restrictions set forth in this Section 7(c).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Affiliated Practice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For purposes of this Agreement, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliated Practice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall include any practice or facility (i) in which the Company or any of its Subsidiaries has an ownership interest or (ii) that is managed by or receives other services from the Company or any of its Subsidiaries in connection with any element of the Business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Blue Pencil</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If any court of competent jurisdiction shall at any time deem the term of this Agreement or any particular Restrictive Covenant (as defined below) too lengthy or the Territory too extensive, the other provisions of this Section 7 shall nevertheless stand, the Restrictive Period herein shall be deemed to be the longest period permissible by law under the circumstances and the Territory herein shall be deemed to comprise the largest territory permissible by law under the circumstances.  The court in each case shall reduce the time period and&#47;or Territory to permissible duration or size.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Covenant Not to Disparage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  During the Restrictive Period and thereafter, Executive shall not disparage, denigrate or derogate in any way, directly or indirectly, the Company, any of its Subsidiaries or Affiliates, or any of its or their respective agents, officers, directors, employees, parent, subsidiaries, affiliates, Affiliated Practices, affiliated doctors (including any physicians who utilize or have invested in any Affiliated Practice), representatives, attorneys, executors, administrators, successors and assigns (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Protected Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), nor shall Executive disparage, denigrate or derogate in any way, directly or indirectly, his&#47;her experience with any Protected Party, or any actions or decisions made by any Protected Party.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-9-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Executive acknowledges and agrees that the covenants set forth in this Section 7 and the preceding Sections 5 and 6 (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) are reasonable and necessary for the protection of the business interests of the Company and its Subsidiaries and Affiliates, that irreparable injury may result to the Company and its Subsidiaries and Affiliates if Executive breaches any of the terms of said Restrictive Covenants, and that in the event of Executive&#8217;s actual or threatened breach of any such Restrictive Covenants, the Company and its Subsidiaries and Affiliates will have no adequate remedy at law.  Executive accordingly agrees that in the event of any actual or threatened breach by him of any of the Restrictive Covenants, the Company and its Subsidiaries and Affiliates shall be entitled to immediate temporary injunctive and other equitable relief subject to hearing as soon thereafter as possible.  Nothing contained herein shall be construed as prohibiting the Company or any of its Subsidiaries or Affiliates from pursuing any other remedies available to it for such breach or threatened breach, including the recovery of any damages which it is able to prove.  In addition and supplementary to other rights and remedies existing in its (or their) favor, in the event of the material breach by Executive of any of the provisions of this Section 7, the Company (and&#47;or its Subsidiaries or Affiliates) shall be entitled to require Executive to account for and pay over to the Company (and&#47;or its Subsidiaries or Affiliates) all compensation, profits, moneys, accruals, increments or other benefits actually derived from or received as a result of any transactions constituting a breach of the covenants contained in this Agreement which may require Executive to repay any severance.  In addition, in the event of an alleged breach or violation by Executive of this Section 7, the restricted periods set forth in this Section 7 shall be tolled until such breach or violation has been duly cured.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt">Executive understands that the foregoing restrictions may limit his&#47;her ability to earn a livelihood in a business similar to the business of the Company and its Subsidiaries or Affiliates, but he&#47;she nevertheless believes that he&#47;she has received and will receive sufficient consideration and other benefits as an executive of the Company and as otherwise provided hereunder to clearly justify such restrictions which, in any event (given his&#47;her education, skills and ability), Executive does not believe would prevent him from otherwise earning a living.  Executive acknowledges that the Restrictive Covenants are reasonable and that he&#47;she has reviewed the provisions of this Agreement with his&#47;her legal counsel.  During the Restricted Period, Executive shall inform any prospective or future employer of any and all restrictions contained in this Agreement and provide such employer with a copy of such restrictions, prior to the commencement of that employment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Executive&#8217;s Representations and Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.7pt">Executive hereby represents and warrants to the Company that (i) the execution, delivery and performance of this Agreement by Executive do not and shall not conflict with, breach, violate or cause a default under any contract, agreement, instrument, order, judgment or decree to which Executive is a party or by which he&#47;she is bound, (ii) Executive is not a party to or bound by any employment agreement, non-compete agreement or confidentiality agreement with any other person or entity and (iii) upon the execution and delivery of this Agreement by the Company, this Agreement shall be the valid and binding obligation of Executive, enforceable in accordance with its terms.  Executive hereby acknowledges and represents that he&#47;she has consulted with independent legal counsel regarding his&#47;her rights and obligations under this Agreement and that he&#47;she fully understands the terms and conditions contained herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt">During the Employment Period and thereafter, Executive shall cooperate with the Company and its Subsidiaries and Affiliates in any internal investigation or administrative, regulatory or judicial proceeding as reasonably requested by the Company (including, without limitation, Executive being available to the Company upon reasonable notice for interviews and factual investigations, appearing at the Company&#8217;s request to give testimony without requiring service of a subpoena or other legal process, volunteering to the Company all pertinent information and turning over to the Company all relevant documents which are in or may come into Executive&#8217;s possession, all at times and on schedules that are reasonably consistent with Executive&#8217;s other permitted activities and commitments).  In the event the Company requires Executive&#8217;s cooperation in accordance with this Section 8(b), the Company shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-10-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">reimburse Executive for reasonable travel expenses (including, without limitation, travel expenses, lodging and meals, and reasonable attorneys&#8217; fees upon submission of receipts).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Sections 4 through 22 shall survive and continue in full force in accordance with their terms notwithstanding the expiration or termination of the Employment Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any notices provided for in this Agreement shall be in writing and shall be effective when delivered in person or deposited in the United States mail, postage prepaid, and addressed to Executive at his&#47;her last known address on the books of the Company or, in the case of the Company, to it at its principal place of business, attention of the Chief Executive Officer, or to such other address as either party may specify by notice to the other actually received.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Complete Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement, those documents expressly referred to herein and other documents of even date herewith, embody the complete agreement and understanding among Executive and the Company and its Subsidiaries and, as of the Effective Date, shall supersede and preempt any prior understandings, agreements or representations by or among the parties, written or oral, which may have related to the subject matter hereof in any way, including, for the avoidance of doubt, the Former Employment Agreement.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">No Strict Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The language used in this Agreement will be deemed to be the language chosen by the parties hereto to express their mutual intent, and no rule of strict construction will be applied against any party hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement may be executed in separate counterparts (including by facsimile or PDF signature pages), each of which is deemed to be an original and all of which taken together constitute one and the same agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement is intended to bind and inure to the benefit of and be enforceable by Executive and the Company and its successors and permitted assigns.  Executive may not assign any of his&#47;her rights or obligations hereunder without the prior written consent of the Company.  The Company may (a) assign any or all of its respective rights and interests hereunder to one or more Subsidiaries or Affiliates of the Company, (b) designate one or more Subsidiaries or Affiliates of the Company to perform its obligations hereunder (in any or all of which cases the Company nonetheless shall remain responsible for the performance of all of its obligations hereunder), (c) assign its rights hereunder in connection with the sale of all or a substantial part of the business or assets of the Company or one of its Subsidiaries (whether by merger, sale of stock or assets, recapitalization or otherwise) and (d) merge any of the Subsidiaries or Affiliates with or into the Company (or vice versa).  The rights of the Company hereunder are enforceable by the Company or its Subsidiaries or Affiliates, which are the intended third party beneficiaries hereof and no other third party beneficiary is so otherwise intended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Delivery by Facsimile or PDF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement and any amendments hereto, to the extent signed and delivered by means of a facsimile machine or PDF, shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person.  At the request of any party hereto, each other party hereto shall re-execute original forms thereof and deliver them to the other party.  No party hereto shall raise the use of a facsimile machine or PDF to deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the use of a facsimile </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-11-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">machine or PDF as a defense to the formation or enforceability of a contract and each such party forever waives any such defense.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Income Tax Treatment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Executive and the Company acknowledge that it is the intention of the Company to deduct all cash amounts paid under this Agreement as ordinary and necessary business expenses for income tax purposes.  Executive agrees and represents that he&#47;she will treat all such non-reimbursable amounts as ordinary income for income tax purposes, and should he&#47;she report such amounts as other than ordinary income for income tax purposes, he&#47;she will indemnify and hold the Company harmless from and against any and all taxes, penalties, interest, costs and expenses, including reasonable attorneys&#8217; and accounting fees and costs, which are incurred by Company directly or indirectly as a result thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement shall be construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation and performance of this Agreement shall be governed by, the laws of the state in which Executive resides, without giving effect to provisions thereof regarding conflict of laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Waiver of Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  THE PARTIES HERETO HEREBY WAIVE THEIR RESPECTIVE RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT.  THE PARTIES HERETO ALSO WAIVE ANY BOND OR SURETY OR SECURITY UPON SUCH BOND WHICH MIGHT, BUT FOR THIS WAIVER, BE REQUIRED OF THE OTHER PARTY.  THE PARTIES HERETO ACKNOWLEDGE THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH HAS ALREADY RELIED ON THE WAIVER IN ENTERING INTO THIS AGREEMENT AND THAT EACH WILL CONTINUE TO RELY ON THE WAIVER IN THEIR RELATED FUTURE DEALINGS.  THE COMPANY AND EXECUTIVE FURTHER WARRANT AND REPRESENT THAT EACH HAS REVIEWED THIS WAIVER WITH THEIR RESPECTIVE LEGAL COUNSEL, AND THAT EACH KNOWINGLY AND VOLUNTARILY WAIVES THEIR RESPECTIVE JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.  THIS WAIVER IS IRREVOCABLE, MEANING THAT IT MAY NOT BE MODIFIED EITHER ORALLY OR IN WRITING, AND THE WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS TO THIS AGREEMENT OR TO ANY OTHER DOCUMENTS OR AGREEMENTS RELATING TO THE TRANSACTION CONTEMPLATED HEREBY.  IN THE EVENT OF LITIGATION, THIS AGREEMENT MAY BE FILED AS A WRITTEN CONSENT TO A TRIAL BY THE COURT.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Consent to Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.7pt">THE COMPANY AND EXECUTIVE HEREBY CONSENT TO THE JURISDICTION OF ANY STATE OR FEDERAL COURT LOCATED WITHIN THE STATE IN WHICH EXECUTIVE RESIDES AND IRREVOCABLY AGREE THAT SUBJECT TO THE COMPANY&#8217;S ELECTION, ALL ACTIONS OR PROCEEDINGS ARISING OUT OF OR RELATING TO THIS AGREEMENT SHALL BE LITIGATED IN SUCH COURTS.  EXECUTIVE ACCEPTS FOR HIMSELF&#47;HERSELF AND IN CONNECTION WITH HIS&#47;HER PROPERTIES, GENERALLY AND UNCONDITIONALLY, THE NONEXCLUSIVE JURISDICTION OF THE AFORESAID COURTS AND WAIVES ANY DEFENSE OF FORUM NON CONVENIENS, AND IRREVOCABLY AGREES TO BE BOUND BY ANY JUDGMENT RENDERED THEREBY IN CONNECTION WITH THIS AGREEMENT.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.02pt">Notwithstanding Section 20(a), the parties intend to and hereby confer jurisdiction to enforce the covenants contained in Sections 5 through 7 upon the courts of any jurisdiction within the geographical scope of such covenants.  If the courts of any one or more of such jurisdictions hold such covenants wholly or partially invalid or unenforceable by reason of the breadth of such scope or otherwise, it is the intention of the parties that such determination not bar or in any way affect the Company&#8217;s right to the relief provided above in the courts of any other jurisdiction within the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-12-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">geographical scope of such covenants, as to breaches of such covenants in such other respective jurisdictions, such covenants as they relate to each jurisdiction being, for this purpose, severable into diverse and independent covenants.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Amendment and Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any provision of this Agreement may be amended or waived only with the prior written consent of the Company and Executive, and no course of conduct or course of dealing or failure or delay by any party hereto in enforcing or exercising any of the provisions of this Agreement shall affect the validity, binding effect or enforceability of this Agreement or be deemed to be an implied waiver of any provision of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To the maximum extent permitted by law, this Agreement shall be interpreted in such a manner that the payments to Executive under this Agreement are either exempt from, or comply with, Section 409A, including without limitation any such regulations or other guidance that may be issued after the date hereof.  For purposes of Section 409A, each payment made under this Agreement shall be treated as a separate payment and the right to a series of installment payments under this Agreement is to be treated as a right to a series of separate payments.  Notwithstanding anything to the contrary in this Agreement, if Executive is a &#8220;specified employee&#8221; as defined below, as of Executive&#8217;s termination of employment, then, to the extent any payment under this Agreement resulting from Executive&#8217;s termination of employment constitutes deferred compensation (after taking into account any applicable exemptions from Section 409A) and to the extent required by Section 409A, no payments due under this Agreement as a result of Executive&#8217;s termination of employment may be made until the earlier of (a) the first day following the six-month anniversary of Executive&#8217;s date of termination and (b) Executive&#8217;s date of death&#59; provided, however, that any payments delayed during this six-month period shall be paid in the aggregate in a lump sum as soon as reasonably practicable following the sixth month anniversary of Executive&#8217;s date of termination.  For purposes of this Agreement, all references to &#8220;termination of employment&#8221; and correlative phrases shall be construed to require a &#8220;separation from service&#8221; (as defined in Treas. Reg. &#167;1.409A-1(h) after giving effect to the presumptions contained therein), and the term &#8220;specified employee&#8221; means an individual determined by the Company to be a specified employee under Treas. Reg. &#167;409A-1(i).</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">*    *    *    *    *    *    *    * </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-13-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have executed this Employment Agreement as of the date first written above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SURGERY PARTNERS, INC.<br><br><br><br>By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47; Jennifer Baldock&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br>      Jennifer Baldock<br>      Executive Vice President and Chief Legal Officer</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accepted and Agreed&#58;<br><br>&#47;s&#47; David Doherty<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br>David Doherty</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58;  January 7, 2022</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;-14-</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>a20220110ex991prguidancean.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i52c554916252411daf203c29b73c5a1b_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 99.1</font></div></div><div style="text-align:center"><img alt="image_0.jpg" src="image_0.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:413px"></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">SURGERY PARTNERS REAFFIRMS 2021 AND 2022 FULL YEAR GUIDANCE&#59; DAVID T. DOHERTY TO ASSUME ROLE OF CHIEF FINANCIAL OFFICER ON FEBRUARY 1, 2022</font></div><div><font><br></font></div><div style="margin-bottom:9pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">BRENTWOOD, Tenn.,&#160;January 10, 2022 (GLOBE NEWSWIRE) -- Members of management of Surgery Partners, Inc. (NASDAQ&#58; SGRY) (&#34;Surgery Partners&#34; or the &#34;Company&#34;), a leading short-stay surgical facility owner and operator, will be meeting with investors today, January 10, 2022, as part of the 40th Annual J.P. Morgan Healthcare Conference, including a virtual presentation at 5&#58;15 p.m. ET.  Based on results through November 2021, the Company is re-affirming its 2021 Adjusted EBITDA guidance of $325 million to $330 million and its 2021 Revenue guidance of 19% to 21% growth over 2020 results. The Company completed the deployment of approximately $185 million of capital in three acquisitions in December 2021, at a weighted average multiple of approximately 8.5x 2022E Adjusted EBITDA and is re-affirming its preliminary 2022 Adjusted EBITDA guidance of at least $370 million.</font></div><div style="margin-bottom:9pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Wayne DeVeydt, Executive Chairman of Surgery Partners, stated, &#8220;We could not be prouder of our team and our physician partners as they helped the Company navigate through another challenging year of this pandemic.  As we have said before, the value of our high quality, short-stay surgical facilities was evident throughout this pandemic, and is increasingly viewed as the optimal option for many constituents of the healthcare system as we look to exit the pandemic.&#8221; </font></div><div style="margin-bottom:9pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Eric Evans, Chief Executive Officer of Surgery Partners, noted, &#8220;Although we are early in the process of closing out 2021, we remain confident in our ability to achieve strong Adjusted EBITDA results within our previously guided range of $325 million to $330 million for 2021.  Having completed approximately $325 million of acquisitions in 2021, three of which were completed in the last two weeks of December, we begin 2022 with confidence to continue the strong momentum of double-digit Adjusted EBITDA growth.&#8221;</font></div><div style="margin-bottom:9pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company also announced today that David T. Doherty, Senior Vice President, Corporate Finance and Controller at Surgery Partners, will assume the role of Chief Financial Officer, effective February 1, 2022.  Tom Cowhey will be transitioning from his role as Chief Financial Officer to pursue a new opportunity.  To ensure a smooth transition, Mr. Cowhey has agreed to remain with the Company through the end of February.</font></div><div style="margin-bottom:9pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;Tom was an initial member of our transformational leadership team when we started our journey to make Surgery Partners the fastest growing and most valued surgical facility company in the country,&#8221; said DeVeydt.  &#8220;He has been a key member of our executive team, helping to build our sophisticated financial infrastructure, drive the Company&#8217;s strategy and create significant shareholder value over his nearly four years with Surgery Partners. While I am disappointed to lose his talents, I could not be more excited for him and his family as he embarks on his next chapter.  More importantly, he leaves a legacy of excellence with the appointment of Dave as our next Chief Financial Officer.&#8221;</font></div><div style="margin-bottom:9pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Speaking to the transition plans, Cowhey said, &#8220;I&#8217;m incredibly grateful for the opportunity that the Board, Wayne and Eric provided me to join them at a pivotal point in the Company&#8217;s history and I&#8217;m exceptionally proud of what we have accomplished.  My time at Surgery Partners has been one of the most rewarding chapters of my career, and I am confident that Dave is the right leader to help continue to drive the Company&#8217;s strategic growth agenda.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;Our Company has been built on a culture of execution and anchored on a data driven approach to decision making,&#8221; said Evans. &#8220;Dave has played a critical role in building our culture and is a natural choice to assume the reigns as our new Chief Financial Officer.  As Wayne commented, we will miss Tom who leaves us as a proud alum, but we are excited to have Dave join our Executive Leadership Team.&#8221;</font></div><div style="margin-bottom:9pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Doherty joined Surgery Partners in April of 2018 and assumed the role of Senior Vice President, Corporate Finance and Controller in August of 2018, with oversight of investor relations, financial planning &#38; analysis, internal audit, tax and controllership.  Prior to Surgery Partners, he spent 15 years at Aetna, Inc. in a variety of roles including leadership of internal audit, planning, SEC reporting and controllership and as chief of staff to the Chief Financial Officer.  He began his career with Arthur Andersen where he earned his CPA.</font></div><div style="margin-bottom:9pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;I am honored and excited to step into this new role of Chief Financial Officer at Surgery Partners,&#8221; said Doherty.  &#8220;I look forward to continuing to build on our achievements, strengthening our organization to better serve patients, payors and providers, and delivering strong financial performance and returns to our shareholders.&#8221;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">About Surgery Partners</font></div><div style="margin-bottom:9pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 180 locations in 31 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Forward-Looking Statements</font></div><div style="margin-bottom:9pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">This press release contains forward-looking statements, including those regarding growth and our anticipated operating results for 2021 and 2022. These statements can be identified by the use of words such as &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;continues,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;forecasts,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; and similar expressions. All forward looking statements are based on current expectations and beliefs as of the date of this release and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those discussed in, or implied by, the forward-looking statements, including but not limited to, continuing effects of the COVID-19 outbreak in the United States and the regions in which we operate&#59; the impact to the state and local economies of restrictive orders, vaccine and other mandates and the pandemic generally&#59; our ability to preserve or raise sufficient funds to continue operations&#59; the impact of our cost-cutting measures on our future performance&#59; our ability to cause distributions from our subsidiaries&#59; the responsiveness of our payors, including Medicaid and Medicare, to the challenging operating conditions, including their willingness and ability to continue paying in a timely manner and to advance payments in a timely manner, if at all, the impact of COVID-19 related stimulus programs, including the CARES Act, and uncertainty in how these programs may be administered, monitored and modified in the future&#59; our ability to execute on our operational and strategic initiatives&#59; the timing and impact of our portfolio optimization efforts&#59; our ability to continue to improve same-facility volume and revenue growth on the timeline anticipated, if at all&#59; our ability to successfully integrate acquisitions&#59; the anticipated impact and timing of our ongoing efficiency efforts, as well as our ongoing procurement and revenue cycle efforts, the impact of adverse weather conditions and other events outside of our control&#59; and the risks and uncertainties set forth under the heading &#8220;Risk Factors&#8221; in our 2020 Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2021, June 30, 2021 and September 30, 2021, and discussed from time to time in our reports filed with the Securities and Exchange Commission.  Except as required by law, the Company undertakes no obligation to revise or update publicly any forward-looking statements to reflect events or circumstances after the date of this report, or to reflect the occurrence of unanticipated events or circumstances.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In addition, the guidance for the fiscal year ended December 31, 2021 is based on results of the Company through November 2021 and is subject to quarter- and year-end adjustments in connection with the completion of customary financial closing procedures, including management&#8217;s review and finalization of the results for the full year 2021 and to accounting review procedures by the Company&#8217;s independent registered public accounting firm, which have not yet been performed.  These customary closing procedures, along with December results and the risks identified above, could cause actual results to differ materially from management&#8217;s guidance.  You are cautioned not to rely on management&#8217;s guidance being achieved when making an investment decision in the Company&#8217;s securities.</font></div><div style="margin-bottom:9pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Contact</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Surgery Partners Investor Relations</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615) 234-8940</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IR&#64;surgerypartners.com</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>sgry-20220105.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bd7a204e-0152-4f82-a7d1-efb1ddd97c48,g:fcebee0a-c2fa-4092-a7ef-c6a9e47d2db4-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sgry="http://surgerypartners.com/20220105" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://surgerypartners.com/20220105">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgry-20220105_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgry-20220105_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgry-20220105_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://surgerypartners.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>sgry-20220105_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bd7a204e-0152-4f82-a7d1-efb1ddd97c48,g:fcebee0a-c2fa-4092-a7ef-c6a9e47d2db4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://surgerypartners.com/role/Cover" xlink:type="simple" xlink:href="sgry-20220105.xsd#Cover"/>
  <link:definitionLink xlink:role="http://surgerypartners.com/role/Cover" xlink:type="extended" id="i74002a3e050240cdbd382572b610c887_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_aaccedca-c180-41fb-a195-2c77fa3947db" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_DocumentType_aaccedca-c180-41fb-a195-2c77fa3947db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_00d70f7e-55ad-4ad4-9b59-41270baa42c7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_DocumentPeriodEndDate_00d70f7e-55ad-4ad4-9b59-41270baa42c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e9030295-e7b6-47f6-8259-3a470eb87b4e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityFileNumber_e9030295-e7b6-47f6-8259-3a470eb87b4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a72d5ca5-de63-4106-875e-180e13a2fa78" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a72d5ca5-de63-4106-875e-180e13a2fa78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_636d107b-0273-4b2d-abfd-102bb364b209" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityTaxIdentificationNumber_636d107b-0273-4b2d-abfd-102bb364b209" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_51556279-3a70-42bf-a31e-84d710a89ede" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityRegistrantName_51556279-3a70-42bf-a31e-84d710a89ede" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_16455494-f149-4bb6-9c45-5e09e7c25543" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityAddressAddressLine1_16455494-f149-4bb6-9c45-5e09e7c25543" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6a1ea6b4-3ce8-4fa2-b238-21aa9c4e3aa4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityAddressCityOrTown_6a1ea6b4-3ce8-4fa2-b238-21aa9c4e3aa4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6c6e33ec-4c5c-40c1-800c-7745f6105d2a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityAddressStateOrProvince_6c6e33ec-4c5c-40c1-800c-7745f6105d2a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7b8ed4cc-c909-4268-a024-d993fa19e8b4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityAddressPostalZipCode_7b8ed4cc-c909-4268-a024-d993fa19e8b4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_eafad7fb-11ec-4c2d-ab8b-c5e1ff69ddd6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_CityAreaCode_eafad7fb-11ec-4c2d-ab8b-c5e1ff69ddd6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_cac421a8-1b8d-4df9-927e-af975def6aa2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_LocalPhoneNumber_cac421a8-1b8d-4df9-927e-af975def6aa2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_64f3d7de-3c9e-44b8-91e3-b563587e3dcd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_Security12bTitle_64f3d7de-3c9e-44b8-91e3-b563587e3dcd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_e4d7f3cf-9036-4f3d-89a6-28d32550e21e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_TradingSymbol_e4d7f3cf-9036-4f3d-89a6-28d32550e21e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_5b6f2442-ef61-4846-bf01-337a6e8ae237" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_SecurityExchangeName_5b6f2442-ef61-4846-bf01-337a6e8ae237" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f9e5949a-f0f1-47cc-9a9e-30c4c6c62ab8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityEmergingGrowthCompany_f9e5949a-f0f1-47cc-9a9e-30c4c6c62ab8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_38ff94e1-54c2-4ed6-b37a-821cd3cecc44" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_WrittenCommunications_38ff94e1-54c2-4ed6-b37a-821cd3cecc44" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_53488ff3-a5a5-4468-93be-09ec7a96933f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_SolicitingMaterial_53488ff3-a5a5-4468-93be-09ec7a96933f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_374b10f8-d4d6-416f-9f9e-8effe9be4478" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_PreCommencementTenderOffer_374b10f8-d4d6-416f-9f9e-8effe9be4478" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_7aa303d4-2892-46ec-8eda-7a4558d7bbf8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_7aa303d4-2892-46ec-8eda-7a4558d7bbf8" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_3888bda0-8402-4824-90c3-6ea6505d58db" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityCentralIndexKey_3888bda0-8402-4824-90c3-6ea6505d58db" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b7f259cd-e78d-44e9-b019-a20d5d5b5c2f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_AmendmentFlag_b7f259cd-e78d-44e9-b019-a20d5d5b5c2f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_ac02c758-18c1-482d-b062-d88a4287ae32" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_DocumentInformationTable_ac02c758-18c1-482d-b062-d88a4287ae32" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>sgry-20220105_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bd7a204e-0152-4f82-a7d1-efb1ddd97c48,g:fcebee0a-c2fa-4092-a7ef-c6a9e47d2db4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementTenderOffer_521252fd-da48-4900-bdd6-2fecdc8c8967_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_5a979c91-cc03-463b-9d29-60b3fe86243e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_1fa739da-075a-483a-b4f9-2febef39c206_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_012da176-104d-4e09-aaa5-934adf7e0bd2_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_a65a1d94-a505-48d6-a1f2-13e8010bef8b_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_dff18542-fb55-4f18-8cc5-ebf33710b98a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_22c6ca4b-6f9f-454b-b26e-d69ed020f8c5_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_9e4e56d9-6677-4c32-bf4e-4ceb0e389b78_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_9775eeb4-4b29-46dc-a1c0-b771f9cd1db3_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_3f817f8f-34af-4e82-a402-050da32f5d5a_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_401ba0b8-8ed7-45e7-971d-31a6a72371a0_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_0f56ccea-67e9-4bcc-959e-b6f26d8a8d0f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_499836da-38df-4879-aae3-483d29d8d49c_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_81a590da-1855-4540-a0d4-3915e34c63af_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_9025d5b9-cdaf-4e58-9820-89989756e2fc_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_e38c296c-366e-4ca1-a3c4-2ed41684095f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_83ee9c2a-d26b-4e86-8569-e8218e1a5f8f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_9a60295b-6760-4bc9-9b13-cf1d6fe8c966_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_6b52ca31-56bc-4b96-812c-ce1cd6e6eb52_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7743a7b6-5efe-4429-9225-87342bdab24e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_4585a6ee-e291-408e-9f0d-cb8847fae16d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_75092b27-dc57-4812-97a7-1ccab723b225_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_09e12078-95d5-4a4d-82cb-7ff79d69f346_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_7ad11b28-0b55-47bd-944c-894334248a8e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>sgry-20220105_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bd7a204e-0152-4f82-a7d1-efb1ddd97c48,g:fcebee0a-c2fa-4092-a7ef-c6a9e47d2db4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://surgerypartners.com/role/Cover" xlink:type="simple" xlink:href="sgry-20220105.xsd#Cover"/>
  <link:presentationLink xlink:role="http://surgerypartners.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_f271a8b1-dd11-4ecd-acf1-333c9c892a5c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_ac02c758-18c1-482d-b062-d88a4287ae32" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f271a8b1-dd11-4ecd-acf1-333c9c892a5c" xlink:to="loc_dei_DocumentInformationTable_ac02c758-18c1-482d-b062-d88a4287ae32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_ac02c758-18c1-482d-b062-d88a4287ae32" xlink:to="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_aaccedca-c180-41fb-a195-2c77fa3947db" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_DocumentType_aaccedca-c180-41fb-a195-2c77fa3947db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_00d70f7e-55ad-4ad4-9b59-41270baa42c7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_DocumentPeriodEndDate_00d70f7e-55ad-4ad4-9b59-41270baa42c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e9030295-e7b6-47f6-8259-3a470eb87b4e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityFileNumber_e9030295-e7b6-47f6-8259-3a470eb87b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a72d5ca5-de63-4106-875e-180e13a2fa78" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a72d5ca5-de63-4106-875e-180e13a2fa78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_636d107b-0273-4b2d-abfd-102bb364b209" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityTaxIdentificationNumber_636d107b-0273-4b2d-abfd-102bb364b209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_51556279-3a70-42bf-a31e-84d710a89ede" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityRegistrantName_51556279-3a70-42bf-a31e-84d710a89ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_16455494-f149-4bb6-9c45-5e09e7c25543" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityAddressAddressLine1_16455494-f149-4bb6-9c45-5e09e7c25543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6a1ea6b4-3ce8-4fa2-b238-21aa9c4e3aa4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityAddressCityOrTown_6a1ea6b4-3ce8-4fa2-b238-21aa9c4e3aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6c6e33ec-4c5c-40c1-800c-7745f6105d2a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityAddressStateOrProvince_6c6e33ec-4c5c-40c1-800c-7745f6105d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7b8ed4cc-c909-4268-a024-d993fa19e8b4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityAddressPostalZipCode_7b8ed4cc-c909-4268-a024-d993fa19e8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_eafad7fb-11ec-4c2d-ab8b-c5e1ff69ddd6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_CityAreaCode_eafad7fb-11ec-4c2d-ab8b-c5e1ff69ddd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_cac421a8-1b8d-4df9-927e-af975def6aa2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_LocalPhoneNumber_cac421a8-1b8d-4df9-927e-af975def6aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_64f3d7de-3c9e-44b8-91e3-b563587e3dcd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_Security12bTitle_64f3d7de-3c9e-44b8-91e3-b563587e3dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_e4d7f3cf-9036-4f3d-89a6-28d32550e21e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_TradingSymbol_e4d7f3cf-9036-4f3d-89a6-28d32550e21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_5b6f2442-ef61-4846-bf01-337a6e8ae237" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_SecurityExchangeName_5b6f2442-ef61-4846-bf01-337a6e8ae237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f9e5949a-f0f1-47cc-9a9e-30c4c6c62ab8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityEmergingGrowthCompany_f9e5949a-f0f1-47cc-9a9e-30c4c6c62ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_38ff94e1-54c2-4ed6-b37a-821cd3cecc44" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_WrittenCommunications_38ff94e1-54c2-4ed6-b37a-821cd3cecc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_53488ff3-a5a5-4468-93be-09ec7a96933f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_SolicitingMaterial_53488ff3-a5a5-4468-93be-09ec7a96933f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_374b10f8-d4d6-416f-9f9e-8effe9be4478" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_PreCommencementTenderOffer_374b10f8-d4d6-416f-9f9e-8effe9be4478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_7aa303d4-2892-46ec-8eda-7a4558d7bbf8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_7aa303d4-2892-46ec-8eda-7a4558d7bbf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_3888bda0-8402-4824-90c3-6ea6505d58db" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_EntityCentralIndexKey_3888bda0-8402-4824-90c3-6ea6505d58db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b7f259cd-e78d-44e9-b019-a20d5d5b5c2f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f382ca64-85d7-408b-b0ba-baa1b68481bf" xlink:to="loc_dei_AmendmentFlag_b7f259cd-e78d-44e9-b019-a20d5d5b5c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0.jpg
M_]C_X13F17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    @    <@$R  (    4
M    DH=I  0    !    J    -0 +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H36%C:6YT;W-H*0 R,#$U.C$Q.C(P(#$U.C0Q.C,W
M  .@ 0 #     0 !  "@ @ $     0  #!Z@ P $     0   :L
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   3K         !(     0   $@
M   !_]C_X@Q824-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R4D="(%A9
M6B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M    ]M8  0    #3+4A0("
M                         !%C<')T   !4    #-D97-C   !A    &QW
M='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:   "+
M !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV=65D   #
M3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#    "1T96-H
M   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $/   " QT
M97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M
M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M !)S4D="($E%0S8Q.38V+3(N,0
M                                6%E:(        /-1  $    !%LQ8
M65H@                     %A96B        !OH@  ./4   .06%E:(
M     &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M%DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H='1P.B\O
M=W=W+FEE8RYC:
M              !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@
M4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@-C$Y-C8M
M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N
M9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R96YC92!6
M:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                 '9I97<      !.D_@ 47RX $,\4  /MS  $$PL  UR>
M     5A96B       $P)5@!0    5Q_G;65A<P         !
M             H\    "<VEG(     !#4E0@8W5R=@        0     !0 *
M  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@ ;0!R '<
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M=_P'_)C]*?VZ_DO^W/]M____[0 ,061O8F5?0TT  ?_N  Y!9&]B90!D@
M  '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.
M#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M#/_  !$( !8 H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
M   #  $"! 4&!P@)"@L!  $% 0$! 0$!          $  @,$!08'" D*"Q
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M @4 !5!R:6YT #A"24T$)0      $'&R'N^RK%WYEXQ?IGQ&?D$X0DE-!#H
M     1,    0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O
M; $     26YT965N=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E
M;D)I=&)O;VP     "W!R:6YT97).86UE5$585    !@ 2 !0 "  3 !A ',
M90!R $H 90!T "  ,0 S #( ,  @ ', 90!R &D 90!S       /<')I;G10
M<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *
M<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F
M"7!R;V]F0TU92P X0DE-!#L      BT    0     0      $G!R:6YT3W5T
M<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B;V]L      !2
M9W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O
M;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;
M0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M      !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M    4G-L=%5N=$8C4'AL0'+            *=F5C=&]R1&%T86)O;VP!
M %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M          !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F-
M60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1"
M;W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P
M4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE-
M ^T      ! !+     $  0$L     0 !.$))300F       .
M #^    X0DE-! T       0    >.$))3009       $    'CA"24T#\P
M    "0           0 X0DE-)Q        H  0         !.$))30/U
M  !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    !
M %H    &       ! #4    ! "T    &       !.$))30/X      !P  #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@  #A"24T$"       $     $   )    "0
M   X0DE-!!X       0     .$))300:      -?    !@             !
MJP  #!X    5 %, =0!R &< 90!R 'D 4 !A '( = !N &4 <@!S $P :0!N
M &4 80!R     0                         !              P>   !
MJP                     !                         !     !
M    ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !
MJP    !29VAT;&]N9P  #!X    &<VQI8V5S5FQ,<P    %/8FIC     0
M    !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO
M;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'
M96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   :L     4F=H=&QO;F<
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M4T94     $E%0R!S4D="                  #VU@ !     -,M2% @(
M
M$6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0   ($
M    %')865H   (8    %&=865H   (L    %&)865H   )     %&1M;F0
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M
M      !865H@        \U$  0    $6S%A96B
M6%E:(        &^B   X]0   Y!865H@        8ID  +>%   8VEA96B
M       DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N:65C
M+F-H               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                                 &1E<V,
M    +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@
M<U)'0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L
M;W5R('-P86-E("T@<U)'0@                            !D97-C
M     "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M
M,BXQ               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN
M($E%0S8Q.38V+3(N,0                                  =FEE=P
M    $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6 %
M  !7'^=M96%S          $                        "CP    )S:6<@
M     $-25"!C=7)V        !      %  H #P 4 !D '@ C "@ +0 R #<
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M.RT[:SNJ.^@\)SQE/*0\XSTB/6$]H3W@/B ^8#Z@/N _(3]A/Z(_XD C0&1
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MDI^JDE\JI)*?JI)?*J22GZJ27RJDDI__V3A"24T$(0      50    $!
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M4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M         0  ]M8  0    #3+4A0("
M                                 !%C<')T   !4    #-D97-C   !
MA    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:
M   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV
M=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#
M "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $
M/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA
M<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M         !)S4D="($E%0S8Q.38V+3(N,0
M                                        6%E:(        /-1  $
M   !%LQ865H@                     %A96B        !OH@  ./4   .0
M6%E:(        &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M        %DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H
M='1P.B\O=W=W+FEE8RYC:
M                      !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E
M9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@
M-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                        9&5S8P         L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                         '9I97<      !.D_@ 47RX $,\4  /MS  $
M$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P         !
M                     H\    "<VEG(     !#4E0@8W5R=@        0
M    !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@
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M)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1
M9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K
M_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F<P%S77.X
M=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[!'MC>\)\
M(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@[J$'82
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MJ+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H # ,!  (1 Q$
M/P#[^8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%7_T/OYBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_1^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]+[^8J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7_
MT_OYBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5?_4^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]7[^8J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J^>/,7GK7+#4[NSM;KA#%,Z(OI1F@!V%2I.94,8(<
M*>60-)-_RL3S#_RV?\DHO^:,EX46/C2[W?\ *Q?,/_+9_P DHO\ FG'PHKXT
MN]W_ "L7S#_RV?\ )*+_ )IQ\**^-)$6WYEZ] _.69)A_*\2@?\ "!3^.)PA
M(SR>I>6/S%L]<=;*^7ZK=ML*FJ.? 'L3X'Z"<HGB,7(AF$MB]&RIN=BKL58)
MY_\ S'T3\MK#]+>99N/.HA@C'*69AU"+MT[DT4=SN,OP:>68U%Q=5K(::/%,
M^X=2^&O-?_.7'FC5)'C\JV]OI=M4\&91/-\R7^#Z.&WB<W6+LJ$?JW^P/,Y^
MW\DOH B/F?U?8P+_ *&5_,?_ *O7_3G:?]4LO_D[%W?:?UN+_+.H_G?8/U._
MZ&5_,C_J]?\ 3G:?]4L?Y.Q=WVG]:_RSJ/YWV#]3O^AE?S(_ZO7_ $YVG_5+
M'^3L7=]I_6O\LZC^=]@_4[_H97\Q_P#J]?\ 3G:?]4L?Y.Q=WVG]:_RSJ/YW
MV#]3]!OR/\RZEYP\DZ7YB\Q3_6-1N/K/JR\$3EPN)$7X4"J**H&P_'-#K<8Q
MY#&/+;[@]9V9FEFPQE+<F_O+U?,5SG8J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%7__UOOYBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKY+\V_\=J__P"8B3]>9T.0==D^HL=R3%V*'8I=BKNG3%7TA^77F=];LVL;
MUN5W;4'(]70]"?<=#]![YB98<)<W#DXA3T;*FY)_,&N6OEG3+OS!JK%;2SA>
M:0CK1!6@'<GH!W.3QP,R(CJUY<HQ1,CR&[\>_/\ YZU+\P]9G\R:VY+2&D45
M24AB!^%$'@._B:L=SG6X, PQX0^?ZK52U$S*7]@[F%9<XSL5=BKL5=BK]7?^
M<:O_ "6^B_\ 1Y_U%RYRW:/]Z?A]P>Z[&_Q>/Q^\O=,PG9NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O_U_OYBKL5=BKL5=BKL5=BKL5=BKL5=BKL
M5=BKL5=BKL5=BKL5=BKY+\V_\=J__P"8B3]>9T.0==D^HL=R3!O%+6*'8J[%
M+/?RUNFM]=AB4T69)(V^7$L/Q497F'I;<!J3Z9S#<Y\S?\Y8ZK+IWD7ZK"2%
MOK^WMGIW4!Y?UQC-EV7&\E]P/ZOTNF[=R<.&N\@?>?T/S'SI'BW8J[%78J[%
M75Q5^KO_ #C5_P"2XT7_ *//^HN7.6[1_O3\/N#W78W^+Q^/WE[IF$[-V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ
M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]#[^8J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J^2_-O_':O_\ F(D_7F=#D'79.98[DF+L
M4.Q2[%#L59?Y#_X[UE_KM_Q!LAE^EMP_4'U/F$Y[Y1_YS"_Y0RQ_[:\/_4//
MFT[(_O#[OTAT7M!_=#^L/N+\W,Z)X]V*NQ5V*NQ5V*OU=_YQJ_\ );Z+_P!'
MG_47+G+=H_WI^'W![KL;_%X_'[R]TS"=F[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%78J__1^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*ODOS;_QVK__ )B)/UYG0Y!U^3F6.Y)K=BK>*NQ2UBK+_(?_ !WK+_7;
M_B!R&7DV8?J#ZGS"<]\H_P#.8?\ RAEC_P!M>'_J'GS:=D_WA]WZ0Z+V@_NA
M_6'W%^;F=$\>[%78J[WQ5V*NQ5^KO_.-7_DM]%_Z//\ J+ESENT?[T_#[@]U
MV-_B\?C]Y>Z9A.S=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5
M=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_]+[
M^8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J^2_-O_':O_\
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MO^DJ/^N*N_Y7O^7?_4SZ5_TE1_UQ5W_*]_R[_P"IGTK_ *2H_P"N*N_Y7O\
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MHK*PB*B2>=@B+R-!5CL*D@?/%7G_ /RO?\N_^IGTK_I*C_KBKO\ E>_Y=_\
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M++;S(LD<B$,KHPJK*1L01N",55\5=BKL5=BKL5=BKL5=BKL5=BKL5=BKR?\
MY7O^7?\ U,^E?])4?]<5=_RO?\N_^IGTK_I*C_KBK-_+7FW1O.5J^I^5+^WU
M"TCD,+2VT@D42 !BI([@,#3W&*LAQ5V*NQ5V*NQ5@&O?FKY.\K7KZ-YCURPL
MKZ,*7@GG1'4,*@D$UW!J,52;_E>_Y=_]3/I7_25'_7%7?\KW_+O_ *F?2O\
MI*C_ *XJ[_E>_P"7?_4SZ5_TE1_UQ5W_ "O?\N_^IGTK_I*C_KBKO^5[_EW_
M -3/I7_25'_7%7?\KW_+O_J9]*_Z2H_ZXJ[_ )7O^7?_ %,^E?\ 25'_ %Q5
MW_*]_P N_P#J9]*_Z2H_ZXJ[_E>_Y=_]3/I7_25'_7%7?\KW_+O_ *F?2O\
MI*C_ *XJ[_E>_P"7?_4SZ5_TE1_UQ5W_ "O?\N_^IGTK_I*C_KBKO^5[_EW_
M -3/I7_25'_7%7J%I=PW\$5]92++;SHLD<B&JLC"JL#W!!J,51&*NQ5V*NQ5
M+M6U:RT*SFU?69X[6RMUYRS2L%1%\6)V Q5YQ_RO?\N_^IGTK_I*C_KBKO\
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MCY$AP!XR'MBE^B>%78J[%78J[%78J[%78J[%78J[%78J^8/^<P__ "5VJ?\
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M[%78J[%78J[%78J[%78J[%6#?F/^8&E_ECH%WYP\P-2"W6D<0(#S2M]B)/\
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M .2NU/\ XSV7_40F*OQIP(=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?3WY#_\
M.2^M?E/<0Z+K#R:AY59@KVS'D]N"=W@).U.I2O!M_LL>6*7Z_P"@:_I_FG3K
M;S#H%PEUI]W&)(9D.S*?Q!!V(.X(((!&%4XQ5V*NQ5^(W_.4'_DT?,7_ !GA
M_P"H>/ AX'BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK^@#\MO\
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M+7S+_P P+?\ $EQ5^&F!#L5=BKL5=BKL5=BKL5=BKL5=BKL5=BKWC\E_S_\
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M8J[%78J[%78J[%78J[%78J\:_/;\UH?RA\J7/F,<7U.4_5K"%NCSN#0D=U0
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M1NCHU.Z,"I]QA2RS%78J[%78J[%78JD/F?S/IGDW3+CS)YDN$M=.M4YRRO\
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M0.Z2+53[BO(;<@,"& 8J[%7V]_SAI^<<GEG7!^6FMS?[B-6?_1.9VANST4>
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M ,X)?\H#J/\ VW+C_J%ML*7VIBKL5=BKL5=BK\:?^<P__)HZG_Q@LO\ J'3
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M2L/VI'/Q.?F=N@H-L*6:8J[%78J[%78J[%78J[%78J[%78J\&_-__G'CRO\
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M].[MFW5MTEC/VXW'=6&Q[CJ"& (5?M_^5_YE:5^:V@6_FOR^U%?X)X&(YP3
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M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]7[^8J[%78J[%78J[%7R_\
MF)_RD-Y_SR_Y-)F9B^EP,WU,)RQJ=BEO%#6*NQ5V*NQ5V*78H;Q5KY8I=BAW
MSQ5V*NQ5V*NVQ5V*68>006U^R"[_ !.?N1LAE^ELP_4'U-F$Y[Y1_P"<PO\
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MJKKXJRD,I\#@0QC%5RL4(="0P-01L01BK[)_*?\ YS)\Q^2XX]&\[1MKNEH
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M "KKS#_RQ_\ )6+_ )KQ\6*^#+N=_P JZ\P_\L?_ "5B_P":L?%BO@R[G?\
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M$7^N*7?]#H_F5_RT6/\ TB+_ %Q0[_H='\RO]_V/_2(O]<5=_P!#H_F5_O\
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MI?(?K:_Z'#\F?\L.K_\ (FW_ .J^/\DY.\?;^I?]$&+NE\A^MO\ Z'#\F?\
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M[%78J_G*P(=BK+-"\^^9O*UNVG^6-:U+3K5W,K16=Y- A<@ L5C8 L0 *]:
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MBL-3R(\7+#N%4X4OKD"FPZ8JWBKL5=BKL5=BKL5=BKL5=BKL5=BKR?\ /?\
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M3_SF'_Y-'5/^,%E_U#I@0^8,59CY'\@Z]^8^HGR]Y,M/KNH+$TYB]6*+]VA
M)Y2LB[%AM6N*O7/^A2OS7_ZE_P#Z?K'_ *KXJ[_H4K\U_P#J7_\ I^L?^J^*
MM_\ 0I7YK_\ 4O\ _3]8_P#5?%6O^A2OS7_ZE_\ Z?K'_JOBKO\ H4K\U_\
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MXJ[_ *$$O_\ J9H/^D)O^JN*N_Z$$O\ _J9H/^D)O^JN*N_Z$$O_ /J9H/\
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MV%+L5=BKL5=BKL5?@A^<7_*?>:O^VYJ?_45)@0\YQ5^C7_/O_P#Z:W_MU_\
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M_H1+R#_U<=<_Z2+7_LFQ5W_0B?D+_JXZY_TD6O\ V38JN7_G!3R"K!CJ&N,
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M ,YF?D=ZZ-^;_EB+]X@5-6B0=5&RW%!X;*_MQ;LQP*_-S%#8-#4;'%7["?\
M.*WYY#\S]$_PUY@FY>9M*C42%C\5Q **LWNPV63WXM^WA2^L,5=BKL5=BKL5
M=BKS/\X?R^B_,_RCJ7D^3B)YXN=J[?L7$?Q1FO8<A1O\DD8J_!^\LY]/N);"
M^C:*Y@=HI8V%&5T-&4CQ!%#@0AL5>R_D5^;%S^4'FB#S"G)]-F_T?4(%_;@8
MBI _G0_$ORXUHQQ5^X.E:K::Y9V^L:1,EQ974:S0RH:JZ.*J1\QA2C\5=BKL
M5=BKL5=BKL5=BKL5=BKL5=BKSC\XO^4!\U?]L/4O^H63%7X(X$.Q5^J'_.!W
M_*(ZQ_VU3_R8CPI?<N*NQ5V*NQ5V*OYV]9_WONO^,\O_ !(X$)=BK]4/^<#O
M^41UC_MJG_DQ'BE]RX5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKX(_
MYSV_XX&@?\QTW_)K%7Y@X$,C\G?\=_2O^8ZV_P"3JXJ_H2PI=BKL5=BKL5=B
MKL58%^9GY>Z;^:'EZ[\GZX*1W"\HI0*M#,OV)%]U/4=UJIV)Q5^%_G3RAJ7D
M+6KSREYAB]*^LI#&XWXL.JNI/574AE/@<"&+XJ^CO^<;/SLE_*'S"(M3=CY<
MU(K%?)U$9K1)U'BE?B ^TA/4A:*7[103QW,:7-LZR0R*'1T(965A4$$;$$=#
MA55Q5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*OCW_ )S?_P#)=Q?]M6V_Y-RXJ_(S
M AV*OZ-<*78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J_G*
MP(=BK]8?^<$O^4"U'_MN7'_4+;84OM3%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%6#_F3YWM?RY\M:CYRU$@I90,T:'_=DK?#&G^R<@?CBK\$]7U6ZUV^
MN=;U60S7MW-)/-(W5I)&+,3\R<"$NQ5^@'_.#?Y:?7]0O?S0U)*PV0:RL:CK
M-(M97'^JA"_[-O#%+]-<*NQ5V*NQ5V*NQ5V*NQ5V*NQ5^,W_ #EA^6G_ "K[
MSO<7UE&5TK6^5];G]D2,?WZ#_5<\J=E=1@0^8\53SRSYAO/*>K67F;1WX7EC
M/'<1'MR0UH?$'H1W!(Q5^^?DSS59^>-#T_S;I!_T74+=)T!-2I8?$A]T:JGW
M!PI9-BKL5=BKL5=BKY@_YS#_ /)7:I_QGLO^HA,5?C3@0[%7] 'Y:_\ *(Z!
M_P!LJQ_Y,)A2S7%78J[%78J[%78JE6NZ'8^9=/N= UN%;BPO(FAFB;HR,*'Y
M'P(W!W&^*OPY_.C\J;[\H?,L_EJ]Y263_OK&Y(H)H&.Q_P!9?LN.S"OV2I(0
M\EQ5Z=^47YGZA^4GF2V\UZ55XA^ZN[>M!/ Q'-#[[ J>S '<5!5?N5Y9\R:?
MYOTJT\S:!,)]/O8EEAD'<'J".S*:AAU# @[C"E/<5=BKL5=BKL5=BKL5=BKL
M5=BKL5>3_GO_ .2[\S_]LJZ_Y-G%7X18$.Q5^W/_ #B__P"2N\N_\8)O^HB3
M"E[YBKL5=BKL5=BKL5=BKL5=BKL5=BK\>_\ G-#_ ,F5/_S VG_$3@5\G8H?
M6'_.%W_DRH/^8&[_ .(C%+]A<*NQ5V*NQ5V*NQ5V*NQ5XQ^>/Y.:?^<GE]]&
MN>,.J6_*73[HC>.6GV6[\'H X^3#=1BK\2O,&@7_ )6U*Y\O:] UOJ%G(T4T
M3]0P_6"-P1L10C8X$)-BK+?(_G75/R]UNU\V^6Y?2O;5^0!KQ=3LR.!U5AL1
M]U#0XJ_<;\K_ ,R-+_-7R];>;M!-$E^">$D%X)E YQM[BM0?VE*MWPI?A?YQ
M_P".]JO_ #'7/_)UL"&.8J_6'_G!+_E =1_[;EQ_U"VV%+[4Q5V*NQ5V*NQ5
M^-/_ #F'_P"31U3_ (P67_4.F!7S!BA]A?\ .$/_ ),27_ME7/\ R<BQ2_7/
M"KL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5>*_\ .1G_ )+7S+_S M_Q
M)<5?AI@0[%7[<_\ .+__ )*[R[_Q@F_ZB),*7OF*NQ5V*NQ5V*NQ50N;:*]A
MDL[M%E@E1HY(W 965A0J0=B"-B,5?BO_ ,Y'?DM+^4'F-DL%9O+VHEYK"0U/
M$5J\+'QC)V\5XGK6@0^><59;Y&\Z:G^7NN6?F[R])PO+.3F :\74[,C@=59:
M@_/:AH<5?NA^7/G_ $S\S= M/.'E]OW%ROQQD@O#*/MQO3]I3]XHPV(PI9QB
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BJ5:]H\'F'3;S0;X
M VU[;RVTH(J.$J%#M\CBK^=_ AV*OT;_ .??_P#TUO\ VZ_^QG"E^C6*NQ5V
M*NQ5V*NQ5__7^_F*NQ5V*NQ5V*NQ5\O_ )B?\I#>?\\O^32YF8OI<#-]183E
MC4[%+L4.Q2[%#L5=BK>*6L4.Q5V*NQ5V*NQ5O%+6*'8I=BAE_D/_ ([UE_KM
M_P 0.0R_2VX?J#ZGS"<]\H?\YA_\H98_]M>'_J'GS:=D_P!X?=^D.B]H/[H?
MUA]Q?F[G1/'NQ5V*NQ5O%6L5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK]B/
MR=_Y0?R__P!LZW_X@,Y'5_WDO>7T'L_^YC[@])S'<QV*NQ5V*NQ5V*NQ5V*N
MQ5Y;^<'YG1?E'Y?_ ,87=FU[ MS! \22"-@LK4+ D$$@=%-*_P PZXJR;R7Y
MWT3\P=+B\R>4KM+NREVJNS(W='4[JP[@CWZ$'%668J[%78J[%78J[%78J[%7
M8J[%78J[%7PM_P YX:]':^5M'\MAJ7%YJ)N>/C';Q,K?\-*N*ORSP(=BK^@?
M\O\ 1W\O>5]$T"8$266FV=LP/7E%"J&M.]1A2R[%78J[%78J^"/^<\/*37NB
M:-YTMTJUA<R6DQ _W7<*&4GV#1T'N^*OS!P(=BK]I?\ G%S\T4_,CR7;0WDH
M;6=("V5XI/Q,$%(I3W^-!N>[J^%+Z0Q5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5\I_
M\Y9?F]%^7GE67RWILM->UN-[>)5/Q10':64^&WP)_E&H^P<5?CM@0[%7Z^_\
MX8^2'\K^0QKMXG&ZURX:Z%11O00>G$#[&C./9\*7UQBKL5=BKL5=BKL5?@C^
M<7_*>^:O^VYJ?_45)@0\XQ5^C?\ S[__ .FM_P"W7_V,XA+]&L*NQ5V*NQ5V
M*NQ5V*J%S;17L,EG=HLL$J-')&X#*RL*%2#L01L1BK\5/^<C/R7E_)_S&T-B
MCMY>U#E-82FIXBOQ0L?YHZCYJ5/6M A\^8JRSR/YSU/\OM;L_-OEZ3T[VSD#
M@'[+J=F1AW5A4$>'OBK]T/RX_,#3/S.\OVGG#0&_<7*TDB)J\,J[/&_NI^\4
M8;$84LYQ5V*NQ5V*NQ5V*ORZ_P"<S_R9;0M2_P"5JZ!%_N.U%PFH*@VBN3L)
M#X+*.I_WX-S5Q@5\'XH=BK[$_P"<9/\ G))ORQF'D[SE(\GE>=R8Y .36<C'
M=@.IC;JZBI!^)17D&4OUHL[R#48([^PE2>VF19(Y8V#(ZL*AE8;$$=",*HG%
M78J[%78J[%78J[%78J[%78J[%7G'YQ?\H%YI_P"V'J7_ %"R8J_!' AV*OU0
M_P"<#O\ E$=8_P"VJ?\ DQ'BE]RX5=BKL5=BKL5?SN:Q_O?=?\9Y?^)' A+<
M5?J?_P X&_\ *(ZQ_P!M4_\ )B/"E]S8J[%78J[%78J[%78J[%78J[%78J[%
M78J[%78J[%7P1_SGM_QP- _YCIO^36*OS!P(9'Y._P"._I7_ #'6W_)U<5?T
M)84NQ5V*NQ5V*NQ5V*NQ5\A?\Y8_D:/S&T7_ !CY<AY>9-*C)XH*M<VPJ6CH
M-RR;M'X_$M"6%%7Y#X$.Q5^E?_.&OYY_78D_*'S1-^_A5FTF60[O&N[6]3W4
M5:/_ ":K^RHQ2_0K"KL5=BKL5=BKL5=BKL5=BKL5=BKL5?'O_.;_ /Y+N+_M
MJVW_ ";EQ5^1F!#L5?T:X4NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5
MV*NQ5V*NQ5_.5@0[%7ZP_P#."?\ R@.H_P#;<N/^H6VPI?:F*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*OS,_YSD_,TWM_9?E;ILE8+,+>WW$]9G!$2'_
M %4)<CH>:]UP*_/W%"/TK3+G6KVWT?3(S+=W4J00QKU9Y&"J!\R<5?O9^6?D
M>V_+?RQIODRQ(864 620"GJ2M\4C_P"R<DCP%!A2SK%78J[%78J[%78J[%78
MJ[%78J^;?^<I_P M/^5B^1[J2QCYZMI%;^UI]I@@_>QC_62I [LJXJ_%S AV
M*OTC_P"<&/S+]6&__*O4G^*+E?V'(_LD@31BO@:. /YI#VPI?HEBKL5=BKL5
M=BKY@_YS#_\ )7:I_P 9[/\ ZB$Q5^-.!#L5?T ?EK_RB.@?]LJQ_P"3"84L
MUQ5V*NQ5V*NQ5V*NQ5X?^?GY/6WYQ>6I-)7C'K-IRGTZ=MN,M-T8]>$@V;P/
M%M^(Q5^(^HZ?<Z3=3Z7J43P7=O(T4T4@HR.AHRD=B#@0@L5?:?\ SB)^>?\
M@C51^7OF6:F@ZG*/J\CGX;:Z:@&_9).C=@W%MAS.*OUBPI=BKL5=BKL5=BKL
M5=BKL5=BKL5>3_GO_P"2[\S_ /;*NO\ DV<5?A%@0[%7[<_\XO\ _DKO+O\
MQ@F_ZB),*7OF*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*OQZ_YS1_\ )E3_ /,#:?\
M$3@5\GXH?6'_ #A=_P"3*@_Y@;O_ (B,4OV%PJ[%78J[%78J[%78J[%78J^0
M_P#G*?\ ( ?F;IO^+_*T(_Q1I\?V%&]W"NYC]W7K&>^Z=P55?D0RLA*."&!H
M0=B#@0UBKWK_ )Q\_.BY_)SS$MY.7DT&]*1:C N_P _#*H_GCJ2/Y@67O4*O
M+?/-Q;7GF36+O365[.74+N2%D^R8VE8J1[$4IBK%L5?K#_S@E_R@.H_]MRX_
MZA;;"E]J8J[%78J[%78J_&G_ )S#_P#)HZI_Q@LO^H=,"'S!BK["_P"<(?\
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MRVS,);R9?]U6Z$<V^9^ROBQ&*OW9L+"WTNUATS3XUAM;:-(88UV5$0!54>P
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MW\V+^0O(UKHMH5^M7(%6).XCC!V+$=3T4;FM5#86LU@TX[R>0=EV=V<=7+N
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M*7V5Y2_/_P#+_P ZJOZ&UVT29O\ =%T_U:6O@%EX\C_J\AA5["CK(HDC(96
M((-00>A!Q5=BKL5=BJE//';(T]RZQQ**LSD  >Y.V*O#O.7_ #DG^7GD@,E_
MK,-W=+7_ $>P_P!)<D=B4JBG_79<5?$GYF?\YN:_Y@232_R[M1HUHU1]:EI+
M=,/\G]B.HZ[.PZJXP*^);V^N=3GDU#49I+BZF8O)+*Y=W8]2S-4DGQ.*$+BJ
M::+HM]YCOK?0M"MY+J_NI!'##&*LS'L/UDG8#<[8J_:?_G'_ /).T_)K0?JD
MO";7KWC)J%RO0L!\,2'KP2II_,26VJ "E[UBKL5=BKL5=BKL5=BK\$?SB_Y3
M[S3_ -MS4_\ J*DP(><8J_1O_GW_ /\ 36_]NO\ [&<0E^C6%78J[%78J[%7
M8J[%78J[%7Q=_P Y=_D;_CC23^87EJ&NO:7$?K$:#XKFU7<BG=X]V7N5Y+N>
M "K\F\"'8J_37_G#?\\_TK;+^4GFF;_3+9"=*E<[R1+NT!/\R#=/%*KMP%2E
M^@&*NQ5V*NQ5V*NQ5AOGWR%HWYDZ-/Y5\U0":SF%58;21./LR1M^RR]C\P05
M)!5?C?\ G7^0VN_DWJ!6]5KK0YG(M+]%^!AV23^20#J#L>JDBM AX9BKL51=
MA?W6EW$>H:9-);743!HYH79'1AW5E((/N#BK[ _+[_G-7SAY85+'S=#%KUH@
M YR'T;D ?\6*"K?[)"Q[MBK[$\H?\YA?EUYG"Q:A=SZ/<G;A?1$+7VDCYI3W
M8K\L*7T/H?FO1?,R>OY<U&TOXZ5K:SQRBGOP)Q5/\5=BKL5=BKL589YB_,7R
MMY2#'S+K-A9,M:I-<1JYIU 2O(GV )Q5\X></^<U_(>@AXO+BW>M7(KQ]&,P
M0U'8O* U*]U1L5?%GYG_ /.67G/\Q[>XT2W,6D:-<(T4MM:CD\D;BC+)*WQ$
M$&A"A 1L0<"'R_BKJXJ_5#_G [_E$=8_[:I_Y,1XI?<N%78J[%78J[%7\[FL
M?[WW7_&>7_B1P(2W%7WY_P XE?G7Y+_++RYJ6D^>-3^HW=QJ!GC3ZO<2\H_2
M1:UBC<#<$4)KBE]6?]#:_E1_U,'_ $XWO_5#"KO^AM?RH_ZF#_IQOO\ JABK
MO^AM?RH_ZF#_ *<;[_JABKO^AM?RH_ZF#_IQOO\ JABKO^AM?RH_ZF#_ *<;
M[_JABKO^AM?RH_ZF#_IQOO\ JABKO^AM?RH_ZF#_ *<;W_JABKO^AM?RH_ZF
M#_IQOO\ JABKO^AM?RH_ZF#_ *<;[_JABKO^AM?RH_ZF#_IQOO\ JABKO^AM
M?RH_ZF#_ *<;W_JABKUCR)^8GE[\S+"37O)%Y]=L89VMGD]*6*DJJKE>,JHW
MV74U IOUZXJS7%78J[%78J^"/^<]O^.!H'_,=-_R:Q5^8.!#(_)W_'?TK_F.
MMO\ DZN*OZ$L*78J[%78J[%78J[%78J[%4@\T^6=.\Y:3=^5_,$(GT^]B:*5
M#UH>A4]F4T*GL0#BK\,_S8_+/4?RG\R7/E+5ZNB'U+:>E%G@8G@X]^S#LP([
M5P(>:XJ]3_)[\TK_ /*/S);^:=.Y26W]U>6X-!/ Q')?#D.J'LP':HQ5^Y'E
MSS#8>;-,M?,F@S+<:?>Q+-#(O=6\1U!'0@[@@@[C"E.L5=BKL5=BKL5=BKL5
M=BKL5=BKX]_YS?\ _)=Q?]M6V_Y-RXJ_(S AV*OZ-<*78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J_G*P(=BK]8?\ G!+_ )0'4?\ MN7'
M_4+;84OM3%78J[%78J[%78J[%78J[%78J[%78J[%78J_.O\ YSF_,P)'8_E5
MIDGQ/QO]0XG]D5$,9^9JY'M&>^*OS>P(5K>"2ZE2UME+S2,J(BBI9F-  /$G
M%7[N?DO^7<?Y7>4-.\I +];CC]6\=?V[F7XI#7N ?A4_RJN%+U/%78J[%78J
M[%78J[%78J[%78J[%78J^1?^<Q_RT_QGY./FFPC+:GH!:X'$5+6ST$R_[$ 2
M>P1O'%7Y"8$.Q5^I/_.$'YE_IG0[K\M=2D!NM))N+,$[M;2M5Q_SSD/7PD4=
ML*7W9BKL5=BKL5?,'_.8?_DKM4_XSV7_ %$)BK\:<"'8J_H _+;_ )1'0/\
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MV*NQ5V*NQ5V*NQ5V*NQ5^/7_ #FC_P"3*G_Y@;3_ (B<"OD_%#ZP_P"<+_\
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M78J[%78J[%78J_!'\XO^4]\U?]MS4_\ J*DP(><8J_1O_GW_ /\ 36_]NO\
M[&<4OT:PJ[%78J[%78J[%78J[%78J[%6,><_*&F>?-%O/*?F*+U;"]C,;C;D
MIZJZDUHRL RGL1BK\+_S,_+S4ORN\PW?D_7!62!N4,H%%FA8_!(OLPZCLP*G
M<' A@.*O6?R7_-:^_*#S+;^9;+E)9/\ N;ZV!VF@8[C_ %E^TA[,*?9+ JOW
M%T'7;'S-IUKY@T.9;BPO(EFAD7HRL*CY$="#N#4'?"E-\5=BKL5=BKL5=BKL
M5>;_ )@_E'Y4_-"#ZMYQTZ*XE5>,=RO[NXC_ -65:-2N_$U4]U.*OA'S]_S@
MKJ=D7O/RXU-+V'<BTOJ13 > E4<'/S6/ KX_\W?E7YN\ALR^;=&O+*-=C,T9
M:$_*5.49^ACBA@&*NQ5V*NQ5V*NQ5V*NQ5-]%\OZIYCG%AY>LKF^N3_NJUA>
M5_\ @4!.*OI#R=_SA[^8GF@K-J-K#H]JU#SOI 'I[11\WK[,%^>*OL3R#_SA
M3Y.\M%+SS=--KMVM"4D_<6P/_&-"6/\ LG(/\N%+ZZTO2;'0[6/2]%MH;2SB
M%(X;>-8XU'@%4 #[L53#%78J[%78J[%78J_G<UG_ 'ONO^,\O_$C@0EN*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*OUA_YP3_Y0'4?^VY<?]0UMA2^U,5=BKL5
M=BKX(_YSV_XX&@?\QTW_ ":Q5^8.!#(_)W_'?TK_ )CK;_DZN*OZ$L*78J[%
M78J[%78J[%78J[%78J[%7YN?\YF?D=Z+M^;_ )8B_=N535HD'1B>*W 'OLK^
M_%N[' K\[<4-C8U&*OUZ_P"<4?SS'YDZ+_A'S%-7S)I484LQ^*YMQ15D]V79
M9/'X7_:-"E]=8J[%78J[%78J[%78J[%78J^/?^<W_P#R7<7_ &U;;_DW+BK\
MC,"'8J_HUPI=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK^
M<K AV*OUA_YP2_Y0'4?^VY<?]0MMA2^U,5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5?!?_ #G#^9GZ)TBS_++39*7.ID75Z =Q;QM^[4_Z\@K_ ,\SXXJ_+[ A
ML"NPZXJ_</\ YQX_+3_E5WDJQT6[C":K<CZY?[;^M* >!_XQKQ3PJI/?"E[C
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?#G_.;GY:?I_R];?F+IT8-[H[>
ME<D=6M96H#[^G(01X!W.*ORMP(=BK];_ /G#+\S/\7>4F\G:C+RU'066).75
MK1ZF(^_ AD]E">.%+[&Q5V*NQ5\P?\YA_P#DKM4_XSV?_40F*OQIP(=BK^@#
M\M?^41T#_ME6/_)A,*6:XJ[%78J[%78J[%78J[%78J[%7QM_SEO^1O\ C[2/
M\=^6X>7F#2HCZJ(/BN;5:EEIW>/=E\1R7<E:*OR3P(=BK](_^<-?SS]=$_*'
MS3-^\0,VDS.>JC=K<GVW:/VY)V084OT2Q5V*NQ5V*NQ5V*NQ5V*O)_SW_P#)
M=^9_^V5=?\FSBK\(L"'8J_;K_G%__P E=Y=_XP3?]1$F%+WO%78J[%78J[%7
M8J[%78J[%78J[%7X]?\ .:/_ ),J?_F!M/\ B)P(?)^*OK#_ )PN_P#)E0?\
MP-W_ ,1&*OV%PI=BKL5=BKL5=BKL5=BKL5=BKL5=BKR?\Y?RFTW\X?+TOES4
MZ17B5EL;NE6@F V/NC='7N/!@I"K\0_-7E;4_)6JW7ECS) UOJ%G(8Y8S]X9
M3W5A0J1L001@0Q[%7ZP_\X)_\H#J/_;<N/\ J%ML*7VIBKL5=BKL5=BK\:?^
M<P__ ":.J?\ &"R_ZATP*^8,4.Q5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*OM3_G
M!+_E/=1_[8=Q_P!15MBK]8<*78J[%78J\5_YR,_\EKYE_P"8%O\ B2XJ_#3
MAV*OVY_YQ?\ _)7>7?\ C!-_U$284O?,5=BKL5=BKL5=BKL5=BKL5=BKYM_Y
MR6_)./\ -SRZ;C2HU'F335:6R?8&5>KP,?!Z?#7H]-P"U57XP2PR0.T$ZLDB
M$JRL""I!H00=P0<"%/%7W/\ \X>?GF/*VH+^5_F>;CI&H25L)'.T%RY^Q4]$
ME/3PDI_.QQ5^IV%+L5=BKL5>._F1^0_DS\TP9O,VGJNH$4%]:D17 VH*N 0]
M.PD#@>&*OA3SW_S@SYCTHO=>0K^#5K>M5M[BEO.!X DF-OF63Y8$/DWS3^6_
MFGR2Q7S9I%[8J#3U)H6$9_U9 "A^@G%6$XJ[%78J[%78J[%78J[%7JWD?\D?
M.WYB,A\LZ/</;/3_ $J9?1@ \?4DHIV[+4^V*OO3\K/^<)='T!HM7_,NY&K7
MBT86<')+13_E,:/)_P (O9E884ON*SL[?3X(['3XHX+:)0D<42A$11L JB@
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MMY1_ZL&E?](,'_-&*N_Y5KY1_P"K!I7_ $@P?\T8J[_E6OE'_JP:5_T@P?\
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MEK-NVGZQ;0W=JY!:*>-9$)!J*JP(-#N,58S_ ,JV\H_]6#2O^D&#_FC%7?\
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M>UFX;4-8TFPN[IP TL]K%(Y %!5F4DT&PQ5 ?\JV\H_]6#2O^D&#_FC%7?\
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M/FT[)_O#[OTAT7M!_=#^L/N+\W,Z)X]V*NQ5V*MXJUBK]7?^<:O_ "6^B_\
M1Y_U%RYRW:/]Z?A]P>Z[&_Q>/Q^\O=,PG9NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*O_T_OYBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKY+\V_\=J__P"8B3]>9T.0==DYECN28.Q5O%6L5=BEFGY>QF77[,#H
M#(Q^B-LKR_2V8?J#ZBS#<]\J?\Y@1-)Y+LW05":M S'P'H3"OWD9M.R3^\/N
M_2'1^T O"/ZP^XOS9SHGCG=,5=BKL5=BKL5?J[_SC5_Y+?1?^CS_ *BY<Y;M
M'^]/P^X/==C?XO'X_>7NF83LW8J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%7__4^_F*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*ODO
MS;_QVK__ )B)/UYG0Y!U^3F6.Y)K=BKL4NQ5V*'LOY3Z*S2S:],*(H,,5>Y-
M"Q^@;?2?#*,\NCE:>/5[CF,Y3S?\V_)C>?O*FH^6X #=R1^I;5V_?1'F@J>G
M(CB3X$YD:7-X4Q+YN'K]/^8Q&'7I[P_'N:&2VD>WN%*2QL4=6%"K T(([$9U
MH-OGY%;%2PH=BKL5=BKL5?J[_P XU?\ DM]%_P"CS_J+ESENT?[T_#[@]UV-
M_B\?C]Y>Z9A.S=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_5^_F*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*ODOS;_QVK__ )B)
M/UYG0Y!U^3F6.Y)@[%#L5; [8J] \L?E_?:VZW%\K6UEU+,*,P_R0?'Q.WSR
MN>41;L>$RYOHNRLX=/@CLK- D,2A54=A_GUS$)MS0*V16!+L5?(OY\?\XZ?X
MPED\X>1U2/6&JUS:DA4N#_.I.RR>-:*W4D-4MM=#VAX?IGRZ'N=!VIV1XQX\
M?/J._P#:_/S6-$U#R_=/IFN6LUI=I]J*9"C?.AZ@]CT.;Z$Q,6#;RF3%+&:D
M*/FE>38.Q5V*NQ5^KO\ SC5_Y+?1?^CS_J+ESENT?[T_#[@]UV-_B\?C]Y>Z
M9A.S=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?__6^_F*NQ5V*NQ5
MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*I1-H&EW#M//96SR.269H4))
M/<DC?)<18F /13_PUI'_ %;[3_D1'_3'C/>O .YW^&M(_P"K?:?\B(_Z8\9[
MUX!W._PUI'_5OM/^1$?],>,]Z\ [D3;:-I]DWJV=I!$_\T<2J?O P&1*B("9
M8&3L5=BKL5=BJ6ZGHUAK<7U76;6"[@_WW<1+(OW,",E&9CN#3">.,Q4@#[V+
M_P#*K_)G_4NZ1_T@6_\ S1EOYG)_./S+1^2Q?S(_Z4?J=_RJ[R9_U+ND?](%
MO_S1C^9R?SC\ROY+%_,C_I1^IW_*K_)G_4NZ1_T@6_\ S1C^9R?SC\ROY+%_
M,C_I1^IW_*K_ ";_ -2[I'_2!;_\T8_F<G\X_,K^2Q?S(_Z4?J99IFEV6BVR
M:9H]O#:6<5>$,$:QQKR)8T50 *DDF@ZFN52D9&SNY$(" J(H=P1V19.Q5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*N
MQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O_U_OYBKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=
MBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_0^_F*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V
M*NQ5_]'[^8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78
MJ[%78J[%78J[%78J[%7_TOOYBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5?_3^_F*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5_]3[^8J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J
$[%7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140292793015240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 05, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan.  05,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-3620923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Surgery Partners, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">310 Seven Springs Way, Suite&#160;500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Brentwood<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">234-5900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SGRY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001638833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>sgry-20220105_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sgry-20220105.xsd" xlink:type="simple"/>
    <context id="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638833</identifier>
        </entity>
        <period>
            <startDate>2022-01-05</startDate>
            <endDate>2022-01-05</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV80L2ZyYWc6NWE2MWEyZjNhYWI4NDc1YmE3ZmFkODJkNzI4MTA4ZWEvdGFibGU6ODhhYzE4ZGI3ZWQ0NDE1Mjk3NzQxYjNlMTgyZjM0M2IvdGFibGVyYW5nZTo4OGFjMThkYjdlZDQ0MTUyOTc3NDFiM2UxODJmMzQzYl8yLTEtMS0xLTI4Mjc2_684c0856-021f-48dd-8b1d-5fbabdc337d3">0001638833</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV80L2ZyYWc6NWE2MWEyZjNhYWI4NDc1YmE3ZmFkODJkNzI4MTA4ZWEvdGFibGU6ODhhYzE4ZGI3ZWQ0NDE1Mjk3NzQxYjNlMTgyZjM0M2IvdGFibGVyYW5nZTo4OGFjMThkYjdlZDQ0MTUyOTc3NDFiM2UxODJmMzQzYl8zLTEtMS0xLTI4Mjc2_5a66b1eb-191c-4a58-97f5-dd378d171593">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV80L2ZyYWc6NWE2MWEyZjNhYWI4NDc1YmE3ZmFkODJkNzI4MTA4ZWEvdGFibGU6ODhhYzE4ZGI3ZWQ0NDE1Mjk3NzQxYjNlMTgyZjM0M2IvdGFibGVyYW5nZTo4OGFjMThkYjdlZDQ0MTUyOTc3NDFiM2UxODJmMzQzYl81LTEtMS0xLTI4Mjc2_77a25b4e-8e9d-4c83-9b52-cf3f418d4350">2022-01-05</dei:DocumentPeriodEndDate>
    <dei:DocumentType
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjEz_ff6f2fad-cc83-44c9-a01a-44d9db076963">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGFibGU6ZGU5NjRkMDdhMGY2NDBjZTg3NDg5MzFjMjBlNDg0NWMvdGFibGVyYW5nZTpkZTk2NGQwN2EwZjY0MGNlODc0ODkzMWMyMGU0ODQ1Y18wLTAtMS0xLTI4Mjc2L3RleHRyZWdpb246MjlhN2JhYTE0NTdmNDg2ODkyMWUyZGFkMzQwMjI4MjNfNTY_77a25b4e-8e9d-4c83-9b52-cf3f418d4350">2022-01-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGFibGU6ZGU5NjRkMDdhMGY2NDBjZTg3NDg5MzFjMjBlNDg0NWMvdGFibGVyYW5nZTpkZTk2NGQwN2EwZjY0MGNlODc0ODkzMWMyMGU0ODQ1Y18yLTAtMS0xLTI4Mjc2_b7a8a033-ff5f-4538-b2da-d32dbd70e141">Surgery Partners, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGFibGU6M2IwNmZiMDVhYzZkNDZhNDhjNGI2YzU2YWY1M2Y4M2UvdGFibGVyYW5nZTozYjA2ZmIwNWFjNmQ0NmE0OGM0YjZjNTZhZjUzZjgzZV8wLTAtMS0xLTI4Mjc2_5ac6d288-9462-4e20-b0ee-f719d6346319">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGFibGU6M2IwNmZiMDVhYzZkNDZhNDhjNGI2YzU2YWY1M2Y4M2UvdGFibGVyYW5nZTozYjA2ZmIwNWFjNmQ0NmE0OGM0YjZjNTZhZjUzZjgzZV8wLTEtMS0xLTI4Mjc2_5310cb2a-80b1-46d9-b913-a123e228debc">001-37576</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGFibGU6M2IwNmZiMDVhYzZkNDZhNDhjNGI2YzU2YWY1M2Y4M2UvdGFibGVyYW5nZTozYjA2ZmIwNWFjNmQ0NmE0OGM0YjZjNTZhZjUzZjgzZV8wLTItMS0xLTI4Mjc2_d1ba2c25-e43d-4338-8247-d44cb8830ee0">47-3620923</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjE0_153d849c-cfe5-4f8f-923d-e98d598f1bab">310 Seven Springs Way, Suite&#160;500</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine1
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjA1_b1d9205c-3bf1-4c17-9280-a640baa819f5">310 Seven Springs Way, Suite&#160;500</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjAw_bbd0988f-b1e3-4367-8dea-0a8274344569">Brentwood</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCityOrTown
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjIw_aa17f600-f3b2-491c-94bf-c35b7602c520">Brentwood</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjAx_5142f7d9-a80a-4c74-822e-4f52ef7c859b">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjA2_116fbe64-1e9d-4adf-8e39-67e418af6b91">37027</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjE1_b692631b-9e57-4c9e-9de6-a1a32629aada">615</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjIx_b271b592-e5cd-474a-a4ed-357aaac7cbf2">234-5900</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjA3_b31dcba8-4100-464f-8ffa-716e03e4a71c">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjA4_2a6f8698-ff7e-41bf-b631-4e8dc447b419">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjAz_059618ca-bb9d-4128-b8fe-5639c3ae494f">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjA0_920e631c-2cf2-41d9-b26e-3cfe12205d67">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGFibGU6ZmE2MmZjYWNlYjYwNDQzZTllMjgyOGJjNTVhZWY3OGEvdGFibGVyYW5nZTpmYTYyZmNhY2ViNjA0NDNlOWUyODI4YmM1NWFlZjc4YV8xLTAtMS0xLTI4Mjc2_77851037-88a9-45b3-ab62-3701b26b2af2">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGFibGU6ZmE2MmZjYWNlYjYwNDQzZTllMjgyOGJjNTVhZWY3OGEvdGFibGVyYW5nZTpmYTYyZmNhY2ViNjA0NDNlOWUyODI4YmM1NWFlZjc4YV8xLTItMS0xLTI4Mjc2_866c88db-e925-401f-abb4-9faab8cc158f">SGRY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGFibGU6ZmE2MmZjYWNlYjYwNDQzZTllMjgyOGJjNTVhZWY3OGEvdGFibGVyYW5nZTpmYTYyZmNhY2ViNjA0NDNlOWUyODI4YmM1NWFlZjc4YV8xLTQtMS0xLTI4Mjc2_b5e3fb72-c2f6-45a7-a6c1-34bc0b1072f4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105"
      id="id3VybDovL2RvY3MudjEvZG9jOjMwZjkwNmU0YjI5MzQyMTNhYjEyZTdjZDg2ZDMyYjk5L3NlYzozMGY5MDZlNGIyOTM0MjEzYWIxMmU3Y2Q4NmQzMmI5OV8xL2ZyYWc6ZTViZjI5YTU0OWRkNGExM2E4YzEwYjAyYmIxYzA3MjYvdGV4dHJlZ2lvbjplNWJmMjlhNTQ5ZGQ0YTEzYThjMTBiMDJiYjFjMDcyNl8xNjIz_75fc7f1d-65c4-4d67-bb85-3cf688eef41f">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M/P]ZU+ND 8(W*/$&I^ ]\)4P5C,HNGN6UN8*UPESO>*0Z1G35G)MSMR87""
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MU^X%^'VIE'UMN)-H^8^$T3=02P,$%     @ J3PJ5)^@&_"Q @  X@P   T
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M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( *D\*E24T7+@200  %00   8
M          " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " "I/"I4GZ ;\+$"  #B#   #0              @ &,#   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( *D\*E27BKL<P    !,"   +
M  "  6@/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( *D\*E2JQ"(6,P$  "("
M   /              "  5$0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" "I/"I4)!Z;HJT   #X 0  &@              @ &Q$0  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "I/"I499!YDAD!  #/ P
M$P              @ &6$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"  #@$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>118</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="sgry-20220105.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surgerypartners.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="sgry-20220105.htm">sgry-20220105.htm</File>
    <File>a20220110dohertyexecutivee.htm</File>
    <File>a20220110ex991prguidancean.htm</File>
    <File>sgry-20220105.xsd</File>
    <File>sgry-20220105_def.xml</File>
    <File>sgry-20220105_lab.xml</File>
    <File>sgry-20220105_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sgry-20220105.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "sgry-20220105_def.xml"
     ]
    },
    "inline": {
     "local": [
      "sgry-20220105.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sgry-20220105_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sgry-20220105_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sgry-20220105.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 118,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "sgry",
   "nsuri": "http://surgerypartners.com/20220105",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220105.htm",
      "contextRef": "ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://surgerypartners.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgry-20220105.htm",
      "contextRef": "ie11c3eb5f6d04a4db4a7c9d96ac4ec13_D20220105-20220105",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://surgerypartners.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001638833-22-000002-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001638833-22-000002-xbrl.zip
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M3>^-RI2&<O*\!\;QZ7@N]UJ>2WSA)*J6&&8"I'&A<GQ5(;8?3&I=9&F- 1S
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M%]<0M/7> I)%39E.J4[9#0FV+N#^7"BW<"@UZ]JDW(:(D3@"LM0-G)/#L,;
M,W7-\YZ+C=&;)-HXUFMMJNL'2)5)8,\+,B;@ZZLBWYB1L\'!R5WC*HI5,UL7
M(+Q8BXFI8!%3XOA5D2&RE2J]NIBR?UA+ _-(<J2'M UZV[!^T6<#8NE:RC':
M6IU\8T1<PZLH23&E!$N"7.H*8VX!68F;XE1$8D!Y4,5+T* RK<)XBLJ&E<&J
M-K="MWUS1ZRP$GRBX9HTF:*TGC)ZT"X;:JQMQIUMMXRD4S-3ZJ8Q9E&;MWNV
ME^^!-_B&/#YA7QW MSJ ]Y\_6@_P@R5TIZL9@7D[\ 9D+C5\#%CN%4@"&-Q
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MZ0XGT<['O_WM;Q]2/PW8QV00SQ046%53K0\[XH\?=L30=N3./GYP_2N2I+.
M_;[E^LDDH+/=, H93,"_V<4;62S^Z;LN"_D_X7H'="?V'?'^F_24>;]O^4S3
M'(/9EE=S59.:(,NT[C3=9HTZ)G,TX\=!-I5\3ELDI&-\-?-W6R',;[8/RXEI
M<!2Z[.;?;+9%?!>&=HWO,_L@NOJJGU[UC/;4';6N^H?-T?&H?=T?75YWQN=J
M;W1DM6^_S=K=SK W:LWZ77?4/QCH_8/VK#>ZM+X:G:!W&]VV#WM6^Z ?= Z/
M9L?=MMH>M6Y[%T<W[?&YT=._F9WQM]OV^,@Z_MY0O^K]6>_"J74N6GK[ L8<
MP=@71V;GP-%ZXY;1'W^^/#[X<MFY/3+;W3VS?]&Z<@\_^_;A>>WX8#CLW;;,
M_N&1T;_XIG8.6EI[=&ET;K_=]$:=H-T=P'CP?OU(/O,=WF6%_6YD'A]^'K6[
MP\O>R WZ!]_4=O<<YNH8G8//?EL_OX%WCF&MM[V@,?O:;:7M,_7F:Q?F,'+T
M'[6&Z:@-JP:*I7F*V7!=I0%F2+$\F]JN8QAUU]CZJ(*RU(Q&PS ^[)28^I \
MW@.3ZZ+9_1S0P1816@;#WJ2[GG_#7,6C 5JJ-Z;?S?3;):9;M%:S-68K6E-S
M%)-:#:59]RS%=8UZP]7JFM4$IG_>^WK6>D1^9U[V!$:.W%;H'H"O+?/=A;\H
M8WCG$!]37#I39HS&"@O?Q.!G8J MB4$=<(AE Q!IL*:KF$[#4)HV0!+',SQ3
M:[BF8:E;'[_0<$KC&;$J',XL"<1.V>#'S&,Q T^:K/!3Z.YV$^YQ060(=W^[
M*7BGW[<2?SP)T/WROPUCE*B22ZK>)"X,L5,>0[Q__E(YAR2:QOP7QR6[4DR%
MC-Q'3+.!&/<[V2_?Q=^>SV+")\16PH7]HW^7+>CBPQ^S/Y5'GW ]R'X!/(E3
MU(B/."G C@IZZ<5K^33=-;=F5[+?V4MV2H3*J)J3<:?@X'< !@@LP,GY,P#Z
M0]LJ/B/QP]@/E2%#D+QKU";I^VO?38>[FJK^8XO?]_%#,J$@47:\ T^+?XM!
MEH>B\0!&2Z/)KC5)X?&4V@'+KMI1#+-6G"@(Z"1AN]D_WF<(1B KA3_T7HYE
M1VD:C7&X]Q 4I+Y# X4&_B#<1>K(R_,Y5U4Q[Q2HD[K9F^7E*K^TD[K+UYJ-
M:E-=?UFM:OFU'3YVG-V0D4ZLUP4['""-?M\RMA86+I>B3U*21('ODK^K_'_O
MY74DV_+%"75=/QSLJD3CKYC/88<3:@4;.&4$D1P09!9O"1YFUV&*4;R;O< #
M00,'/O:#V>Z_NOX8S$6'79/3:$S#?U420-4 OV/?$S<F_BW;U1K #O[S6JR^
M#N-PWDEJ:#K2\KQSU&T=D+/N7K=U5A:=9SC;L];^^>E1]ZAU1O8Z!Z3UG_T_
M]CJ'+;)_W&X?G9T='7?6+F%95A]^4?I&B[J@R1"D)XW""CFH[E?!<5AF<\.%
MH#4HJ'3S4=:U&;,^ Q0ACX" 1+SVE(#F)@,T_>YWOP_C][KGZO'%Z27(YDU;
M;YD 6*Y[H[U9;WQTT[O=,]JC'H"3[Z;[QY>@KP=7]F@2="X ?(R"8:?[S>H?
M?E-[77A?=PB Y9/?/OCB]T8 7@Z<62=HW'1@+C\\K^;I'G45![&(:3I-A:H:
MA7^Y3==6Z[5F#7!I0_GW,@C92+2,LF@9=XC6*L_SJ.9C,TT#XW':ZG3):>OD
M^+3[[*=[,HV3*0U3DD;DC#F8,R&:0:*8:-:V^XY$'DF'C#S[=<#<I[&?^C!B
MZ\89 L9E9,])<?X:H*#[6;IU%OQQX4Q3KP).?1PTLPZZ9.A#G]P@_BA2)6#>
MTB+$_+>>FZ1P6B#81K$X99,H3LEV]ANBU@#$)R7L"A/+,;_,W'>[A#R&AWF!
M,?8]79*(L?N'YU9G='K9/G"'\$Z]<_!IU.\.($X>P#S!#8T^!?!OM7/17HBQ
M)Y?][J7>.?QVW=%;L+Z>VC[L!,<'CGI\<'G;OFC/VH<PCX-O6D]K7'_M[I5B
M[*_&:<#^.)WU+]R)K9LU[@[U+T-PA6JGZX[AG3J,,VM?G,_ZAY\O@6;7[1$^
MV_$ZW=ZOA>C__+M64]^OC=-+0=3ZF*)Y1TRQ/BRXES(+S5RKSH\,\83M>NB<
M]2D;^ F6#=(.7'E3J9^IU&Q1I7[8==J@JF$HGF=YBFD9#<767:JXAN[:;EUE
MFJF!BY[& Q;/R F-TY#%284<A4YUK5:\($%6%P397"G(VZT;"H@$A4SXGTSL
M"$W(V80YF'IRB1^2_2&0B,7OEFFQ-M9?QC'/ KA8]TO#&'I5;1@; 9=?'-8R
M'F18M6$^,,QZ4H%^(LL,]B&* 8;Q4NY9"C!H/YJ&:3S;C]PR1L+*,"9=4S:)
MHRL<YT6#H[9^!//J0TS^?=B[[5]V#OK#SL%P!._5>[?G>N^BI[7UGMG6SQ<+
M$+<PIMX?P_,7GT<P'[4S;JG'AVU88W_4Z?:'_='Y;7\TN.U_7P9'/RSJU%R]
MT5":9DU73*:KBJTRIGAUK>G6#+-F:$V T"R@US1F=]KN-PG?0,(_^P&#T6VP
MSF_2^G-I7:R:&IKJV#I5&JJM*6;-;2IV4S,4JND&T_6&RVP'"SV:8M2M>NU-
M7/^JN';IS9$LDCG<*+_)[L:R>U2675>SJ>[HEL), ^)( S!S0S?KBFN:CMUH
M&&!U(8Z$/Q@U76WJRVT>+P\G-S>#R=S18P;R.!VRF'R9QG[B^CPUR5/ @)U+
MP.#=R]'C#2FP'XW'?I)D"T8G082FO;ZU'IV>D=9X$D0S%O/5E@T,Z4357XF#
M'C[+^%-3K#^**=YSW9@EB?S/5YB ]B+-\%\J4*D_-,MP&V;341R/6=BZZRE@
M+%V%-1NNU6QX8&7M-VX\"C?VM!^VYC9UU7(4P_8 D#E:';C14!5:,U6;TH;6
M]*RMCX#:R!EFV<G9) 9+E9 +.JN0LZF?,IDQ5=6574V;%!C_URS /OSS..Y&
MUR\SX/U+$G?]P[9=M=D K;<U9@",JM45@/U446E#KYN&:5JUYALO'H$71]<_
M*-7J7DU5%<^P=<7$3M:F:7N*8UAVO:;JCJ4#I/T4@U9>1Y'[,PVO/&39K<0V
MCCB/XY,XNO+YCH/7F%GZ2XIV\\/23-VK0X1-&RH%TUXW(5[1&;A<2V=>W6E8
M37"T71:&0%"VE!IZ-%Z>1,"LH.]/1([P?XU1^@]-JWDVJYF*Q@N4U/64!C.:
M2JW.3*U!O9K=U, 'UU6]?L^FG775A<<-'[B3W99<QX+*"6 )QY_0@+1NF#--
M_2M&CCT()%CRCFR#1! 4B7?/'CAL/Z"JH(/:BQG]GU2.%@#46E.O&9JM-)E5
M!RO69$K3936%:M30:WJ34I=N?:QIUJ)JO'M( _8U@F#\9!B%+SD7_)? P\T/
M6Z]KMM74%68Y8+;J)E6HR5S%L.J44J?NV)Z^]5$W3,5JKHH.GDJI-[13\VKO
M/__>T+7Z^X1T6< FR'29V^'U\&"*N1N".GI/<_74?9*+!%EMY#I12O8FD\!W
M,)'S?&:[AGW89\QB6;N/B?PIG0\PSL.:?3A@+CE#!$F^TB25'6;K.5CVJLUR
M[V&-M_,\P5KWA\RYY$V?= *0%R)T3,?:T0VQ61!=$U]TA/+.ZX;R;^+Y 4JL
MGQ ?=[.Z0(,T(HD_G@8I#5DT38(926CJ)]Z,/RD?B&Q@J\CQR2;3>-X1,85Q
M8D+#67;-BP)X.3Z',-S'W&BRNR%E&V6\,IHFJ>_--J?N!;P6M3+Y2W1]0/]Q
M$?LID![3QM-0)DZ3Y2C&CJ+ ID#'%+CY/^=C]HP?MJ&YCDT;BJE!E&K63(#&
MGD>5NE9CJL& Z)JS]?&??V_63?/].A?S!"HIDF++_R_Y#K)49#R9%'JZ3Z<!
M(Z9N28U"52JT2F.']+96)_N?3XENJ%6X<5-S]>J5ZBP"YP1D"@=M,(!@!8,W
MC5K0*/.'3FM>H]9L*)Y79Z!6MJ?8@*\5DS5<QS3KMHG](B]'H^9,)V/)]65U
MT@";:GI!HTH[#G)],M6JN/--I:1*G<0,?11N"^:;JA MQ!"B8\3SIEHEU;K]
MH5K-FM9PJ&+;F,?1](9B-SRF6#6CZ1B4F4W3>TFJ!<Q7G +W?^JU---5]&W[
MW6:*)NY]4[75JG:4)%,6ORG<>H53?S1UE8'O<A3=\710..PFTVM,,1R/:4!A
MRZW57[?"&>#"MYW-%$[>NZG"/:.<<0'_BHB3Q1"S3E9MA.3F1T:@0(%- \Z%
M4%Y;V87S^.WX9M4TS7NUXQM5K;99@_NO#&M5&]KZ)^\[JE:K6F;]A4R64W:S
MR;Z,'K_-]G1U\2@SL>G2&1(GH$GR"XUMI;UNKX$:,>5)W[/9V(Z"[>17FOQ>
M&RVRW5%<,%CF?< 67P]]^,O<8/]*_VOA8!5M[<$J+Z)=\B'S'<(MSC3=YNKY
M(B&@W @Y;NGM<7_4NX#WCGK7G8-OM_UN$+1'@]GQX9=1I_M]V+_H&<>'K<6-
MD.->MS?KCV$=^G<?86'GH!,<7YS/C@^.S-ZXK74N/@?]D6/V<(Z+VV?J]8:E
MJ49=:31H4S$MVU"H7=,5HZYJ@"5MG6(1"X$Y2/19&CF7%3*A,;FBP921W]2J
MJI$)GETU_&N[:S:P"F\ZL8%.2,LL#/.;0FR@$ N['!JUFM-HN+;"FKJEF*KF
M@4+8IM+T*+4;CJ-9#0\0^>%I[TW:GUS:,P^0!7UB._QBG@"=\@MN@WMLA?BV
ML%7>8H9GUW4\0[H&'H+6%5IS-,4P;4>U-;6N>R8@0H@W.S1QZ9_D,(AL&D!(
M&D!02MHTOF3IS_<";;A/O/%41>:CT,4\!"/VC#B\X P3NP20Q_B>GX5JL)\0
MF"&#Q0X0)P_BZ#H=8CIC@A5BFA"7>? *OG>^_$N4OU0K"^(7:E_B=""#;&/&
MI/Z>E\"RF^&EH 83W(>/)7^1(=%M15\QUJHCA_)!,5LR?ZXP;'7S9.73<*FU
MAN+XOU],>#W[A*EH(LU6?,@7O"_6^Y8K7>C6NOU1MSRG[FFN4K,<4S'=6EVQ
M[8:%N=):H\&89VH_+T[D8O\T)LB[PZA4P'BLM%#^4JO*$"P.-\Y@<<*(YP^G
M">-W@6S*AA@\E-[G.45QO"M*%']7,,.7\Z\7H&:%L#2X$K,K/X'GP([1T,$B
M)'4<//H ;\9C\5T:NXEHA7'7)2^-;9HG+W,#]=Q-#AC0ZM/9E^@7RD=OA]P^
MBT-NBT<63R*A9+LQ"RCV?R\=8CR?)9^>.G^$VC"5:;K\R,_./?[5PY?K^>'+
MPW@>R0R88L>,7BK4 VBP2X-K.DNV=M:=T&SJU;IUOT.:'[VI7=/1VJ9L3/2J
MJA-RRI)ID/*6_6.PAK(:!3:-?,[-W7X$YA<O;(J1%DYNK*VL[XH_@66'J(X?
M/_;X)T%Q,]-FV._+*0!C >]Y>0Y^K3XBBVRC"<>^85U]+S$)_Z6]?P>N(PB(
MS0@$9&GN2OSPBB5IA*\(279<O*:*<^@JB)$G\(;,.9CJ@U0O:U5K VJL4%ID
MH&)45YA!_! .#K#U,1T^R)PW9"#9"X&F ?E2/:F2=A0/8 I_,!JD0X?&#*57
MGGZ/."+KZ:;DRH]3?&P2LP0X+II?:4JL7<TBD^H8.-VBF-X."4[W795\H@@#
MX*Y8*DTZC*/I8$@ZT147(N2H5N%LE)*!T5+,P(YX?CSFG;GP&-Y%]ES4 QBO
M]>FH>[!'!E/?Q2_LH!S\9N@6 4H%."5 $;\9AIK_1MW,1SG%G;M35GI::_X#
M']*U?Q"8%Y^4FDVY2KJ%R7',PW 2.&67X<;_3/IYO_&-CXU7P8S\IC7F,X*K
M#IWX*1 /HCH@ F, B?Z<^D)VL/>8'#"G2!*@*R6"B_ V"M,"12/8E>Q/1/&I
M_+Y&U;KA^M%:(A1?_PJJ A\#'WZA=O$/2]U%89A/P+ M_#>CGI,6L$YWR%NG
M\T\6B4YJ%!H9T +MQ%D7C)P4!2<=PI!C.D/MGW*T&/'(.<F-04[[E<]C5'U%
M_8##%CY>SJ9\C\(ULX'"#"<OOZ/@Q]5$6*F)-%)5X.D./S0U48!22E&ZDYW2
MKU=IS9'$.:,E#P"Y)V"V")[32D0,D(NGH56$)@$#[$7]EB8Y4Y>5ZI[)8S*U
M1Y@4 LW[<\I/#%3X)7DX+ @]%T=4+ZX@$"Z',CC@7@)?)/4QTS&X'0@"XCR/
M/)P #+3HNW>8.X6)%HW:W'_E,H/!"U 69X*C!/[M0I>_6&E.J6D@Z92O#194
MB'?D>//W8TBV2EA1%":,RT.YL\,.?*<X(NIP1584AV 9>-PV8REH$N,1&BHC
M<[GV@#;-J;**%C2(,K>;LUBNL0+DG08 DRE&A-3AQC^WY!%Q?6S%RCM-P0CQ
M;]>MH&DF7U5R@D8$!@N2B/"/K.! '%UI>QE&./632_(9W@<(0 (%839SFOTK
MR5R8/ 89^,-W=&@J;NF0K+E#>E7!J!5<^"9$$18CADZ*8W_+QY82F\CQVS0&
M9F2J42%?IB$CAEJ9"\49FZ1R"FIV%_X= BI@$+=_2+P45!M)PO_KK[9JL9R8
MYP?9IP,7$GHX<!XSSX_CJ9)>-"7HXH&E*-3SF#]&'P(KO8-Y(%X<!SA#'\RE
MB]E.O/^2_S&4H(T[0Y<Y?(O+N@4D^4Q?I45==*/HJ0H6:0P: +HG'""F7Y %
M0G6!LS26?A/T/19TYQP>,'!67,G@"LJ26S0)$[%Y.&!)1O/ST,=[^-D "29S
MN6H=[NV=Y-A[G0KP!+1(]^ M:&.G:<$(^CCE4,&Q5BP+7?H5M\%<GH=1(OT[
MF+V(I\=%D@JY+]!#]B32 @%)FL54/&\. AG,.(H&.8T"/J5DR V3(!PZAL1W
MN;'T(0J6,XWY\^AE0#C2J3B3"S NP%..TU'J0S":0+A(;(L#ZP@V+Q)!'6*D
MQ2MR2Q=?A)PT=WGS1Z3QY6R#&?E7JYF)I"L#2Y'T3S@_8(KCS!8NR%)F#FF2
MS<YF\$*6_4KI#:I_]A!:J\(::9K&OCT5F1Y</G 1D]!Q%(A-<%@M!"6&M8(K
MBD&+:2X%= PV1_K"2GXG83?@LA((%. U%8*?B4QGBH %R&:X)H;([^.Y1.K,
MAQG$A9?,,3$\SB>"I$?#A(FG* &_(:PF0Z9C\D7(BGR_#\0$Y\B[18=@+M#!
M!3"<W*B7L#0-1+2*@PA&%J[S5PJ9A\"- N/$+:!)XT3HZS7P-9*"%Z =Y.8T
M9G.<>,7A<C2-8=:#B&\5S-,$99Z#Z$_#C!=R )#8/S$5ZLNA8ERHXP=^KG^+
MUJ4DQCN<7)F3$LG:)!L;=9 )9UZ(VQT:XG)BD.<(9S/#V_' .B&JR13/(/ %
M*(%IV#"7%(P0H!Z)B "4L23A^ (6!DXE%$!PXUD)JK@,Y=X/2V@+I&X:II+V
M2&EV(T,+;EWN,$/<Z (T@4$7$A6CJ3O(94! +F#$!.417H?\XDSW!  1P2G,
M"@>5L^(-QB+U+>4:;4.F9&+*K]*S(9]*L5XHW,'^-,9C<3(TAI$!QPK>- []
M9(B^BEMME!IIM%T&W' S,\>A3&;<4% F4PCZ$F%>\Y) 8^/:92'C5+PA=WWP
M!L[E:Q]X5PA$\+E,R''TK)4<I"^;Q;J5P-.VL,,R7.4>+_^0(-JZB/N/; .Q
M6,KIXJ[A.^J\T7)7^PHQV_ C>NK*K^C]Y,M93W2F" \0+)Y^/4"(E"GC@0_V
M420*8[(O;;8X-"5.WI-6('E6O/4];MP'NYQF>9OEY_8SSQ6!4=N+8R3V.#-K
MB[??7]$?CIA\Q%W,-_G.!N1=(,@!O?)=TJV2@PA4).4M"O,S:;[#JGDFAG]O
MDJO#/D0$7B']+4GS&BW@\:J$=#'E@=YT"OKN9F<0W$E9/&J Q8@B[D?BA80+
M(# (R1T^".72^IG9L9BMF&QUTQ+JB^)*.\Y)6B%FLT)&$6^A62Q(H,/:@UB)
M8Q==!8?"46>23,>280"%F? YH0\VI<R)2B$7*5C!!',DAD:H""^8#H ZV1LJ
M D9A7CG!&>/?L_H&$34#CE_G"&82@ RAA_@G'4_>B_@G\1,)ND.LID]='R8#
M8%\&:-GKDZ$_J1(\2BKBB97E@DR!4B29H'1I%D^4))@DW6-I2&75AN=N(9#S
M6<J/L4#*)(746<"_WHIOE)<\CH'*4\S64B%GK7V9N!#Y@L5I2TX0APLZO"])
MJ>=E/GF-^,-:_\ 0" L8O#4)("(P@5-\+TZ' ,+WT*D"SL2$&<,@D^&GLE X
M.' YV7N50&T/J#O)3Q^9\#/&0-A$[DU8*&1#01KRZ+]HLNYKE3"2YQD-D:*"
M7T]7[A(LP8!1!&&[ KWS,ESK9NC;?DJ:S:KVI 4Y+N;+0#I+/>)!-3)K7@*8
M*-&@IT6<^5+%>2UD6=?;EY?>]@8Q$Y&=R&(O^-@72H]-44A]%0CA;=\\]<1C
M#L+FU*)E:A7]02EJ6D'?+'JJDN)G-[.,55[\6?5HV?'XF#9/<9>.*W+/#N.(
M!8,KGM7'!!)):( +Q.JNI5D5H&BE&*K-JT/HN7@YUD^<F!73!Y\B&KL+@4*Y
M0E5<,[^[&")BD=0%>S<(&:N"5R38WR,R5XO+ 2GQ928'W4MQ+5$X362+'+AL
M<,BIS!%@NHQG-4G=^@=.;)4Y+I"B,L_URP'034Z=H7R'B$"S/(J(/PM4**]G
M7KOCXXFD?H93BVG,081)M[5:M-#1\X0]3$_3C_07K,D3&0^ GM0.1%KF+@D1
M:;F5AE9J;U)2 TQB4NQW\2<(D/%#<)DY$A](0*06,@_\[22.!C$="\PH"IF)
M -PL@QM+FHK9OWD1)%.XRF+V1ER024IPF?,I^;Q._><43($(YC$!Q. M11MP
MP0(/W_1)S#3);=YK="-K^<O+L[(]5R9?BYS.FK8&F+9B;H7D]98DBO@>AE(V
M&;/]_)S$PC%XI9,=@ <(?GCL=4_(60'CB@6)V.>=S EN3B3XE2]N_OF&Q(2_
M%,L _.)BY+QV(^-B_UJ^^3&3#;#+ -:&Y#<=7!1P+#.JKOPT+R=3:933^4SY
M2&3ONN!ZLMI^H4<"@[& %]\G\#/)PZ*%RAT$G!8Y'H>^#>X HCC44R#C"41A
MO&V.CD6Y&@F)U.(@<IXRR#,;HD9>>F2;YB&%F-TU3>;P/@/2FEK5ZMBXO6:"
M=U7M^5CP)U%+E]D5[5V)<.4UE2J9.;#)LK;2KJ!_Y()0/C*$QT4!NNDX%V1A
M\58S1P@]QNVX7A@@PO;GH2\$C/M0(6VAV/R='?SHQTF:=7Q!*(QI (RI<_-6
M$I)*P<(5[!I&RGXX15[-M35[$4X)-8H/5*Q=2?S!*ZI)(;E<IB$F&-S7:-R6
M#!8W:C:;8S6/%W0YD43A4C!A/:VRC0[94V4TAT"U(2Q &:ABGQY8EC(HW>8O
M)W2:#J,8EL7KI6,\$)%ECND=JCV77P1CR<;(#I[BOW,X_+_EO&1/859-1-OE
MOT.*%24"ZWW$4$%K9HFT3H#NKT2)7IY+&4:I[V1B,D,RAY'T;!48<WE0O#-K
MM(@B%RP)OS>K:\$C\ Q_\RJD[S**B<*X8.OHA#I^FG5+X[5M_^K=0@,9;Q7%
M9CML&2I,81\KO85'47BC:4KXWZL$3_U=-8V"B0$'5*#BPENSX=:\S?>(Z)8#
MT4E^1IE5X&)%A+@,]@12$ $?S3-<V H84'^<Y'E&83UYMZ _;\.0_7S<VJ..
M.]$5"[D%P&=HM@MS?5"+@J7IA'_<OA2J 9J8<<0C'T<%YD!$7)53DJ7N*VEL
M-%WA(\TW665HJ>@H"E5R*87ET8216<2QHOI^S0)8YK:FO\OFG!,RQ:5-<.PD
MX=9Q;@1+T3W2^ I]:([EP3 F60B>X/DGV$:! Q>YB@TK7IG/F(U%"RAHG\<(
M95R6:8WH)F6AXL@,62FZEA8X(_K"NY'7P <C6S./"<6RP[GWSD_S%GV#VV7*
M8*UW@JV<XD#H"?7==Q7^'Y$H#Z;C"4CG.".$Z.-#X,QGB$TYO$]D, 4!D /P
M9(%<=O)>J#:72PGS<IB"27/!6N[QU^#<(0O<18LDBD!"=+)#:-:)\X*Z\\F7
MVW1Q4;*Y)T,=17"&YET1+?^G9WMS-(L-:P$3&<OL.4GU\B/9@K.;>%<V"8$%
M*W7AUQ8$!-Z0OL7LAR#P- 1!_QF5[SNQ>2,@3YF#-N.VD2Q[)VDK:Q8BD,D=
M2C%A)VXX.3M/-J)\X?X')CO:X.TK?YGV/R>VC^<^NE)AESK0*_\=9O#^'\D#
MV4R]P B8:X%<E95N,T9H4H2.=!XUV*)-?,8IC)ZTF'H+^=<3"E&JZ#/C#8YV
M7JQ:'#<?HD@_V?ODYGWW!1NW:NG5!\8 &\$C>3^6-^5Y:NA&I<UN"H2&_:VB
MH@G_/W>X<^FD1+;$B'T"6%>\,^4,A!46& EJ@P<F"<,M-J+-6;I,;MBQ81Y\
M MIW!>T[^)BQ< @DH,*/T!Q)%F;$<?M"1]N<K*\2D2]6!38J!-C@N;E<96'K
M2D!6W+,ANE;'$PAM"LVH69N5-#*RKC[T)XGHL\>G$G$\=I8*E.^))#ZE&>["
M=JL5,I9!H0)#,6M58.KZA*G<$94L-);.MV9PC%5<Y:*QA!@RG7<S@8Q[/"?F
M\RUE\XX\WM,8.5.>",$$#N+O+,F&A JP)TKLXL.^5&""M%PB)^2/;>!BGI:S
MIPFV)2=9G^/K;&LLBB3Z89XI*-705NYBD <9Y. >%S(.Y]_^I7.A7TR>^6MR
M9R:R>@]3;IP#G:A*M'6YM*QSD+^+]_EG>2&>5#M3M'E.;;[[1#,K/$WX*AG9
M%:$6$WW7H&].[$^*8=%*Y70C)C9A\*;3.)4.(MOKN;Q?35@4+-X!LT6,B/X"
MU3'&;AE[5IGO#4/2W%T:S46B5-N7<@=_GG<_EAI*X?+S[JI @7[2KHILM\KZ
MKHI7T+QYRE,LN4OJ#N$E"?E<!7MQ/62OO?W!RMH?%M==D:W2_X6>2LP#<CW?
MK*5 X@+^.:E4[D<7>3"Q:8$WJDF)Q))7E7!,)*:]N"E+.!%W7H,3MQ7V LZY
MOW+T0B2Q5.>1@110SYX61Q=.4+X8)S]&R)*GS!9W]Q:BC+S=5/2:'H5\ \M
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M!P_=1;E9!D[G+:SZ-[NSS8L73L11?CX[VEWN7_I_;S@[^@]02P,$%     @
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M?4I7NBLHU:?B<Y%_2S7$.4Q8'%#)@!^'NA<D 0,<)[2:<;E* BJ0'YEJ<-]
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MX\1"M6#"2J1](3L)=,?9:.+L"Z,IS%Z;@:5TU?U_*J[R^VR.0Q*R2"F@$(4
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M+U!+ 0(4 Q0    ( *D\*E0'TYM:!D@  )": 0 >              "  0
M  !A,C R,C Q,3!D;VAE<G1Y97AE8W5T:79E92YH=&U02P$"% ,4    " "I
M/"I4V3.I0]@1  "A.   '@              @ %"2   83(P,C(P,3$P97@Y
M.3%P<F=U:61A;F-E86XN:'1M4$L! A0#%     @ J3PJ5+*U!#3C)   9,8
M !$              ( !5EH  '-G<GDM,C R,C Q,#4N:'1M4$L! A0#%
M  @ J3PJ5*[^R15X @  =0@  !$              ( !:'\  '-G<GDM,C R
M,C Q,#4N>'-D4$L! A0#%     @ J3PJ5%I^$WI7!P  US(  !4
M     ( !#X(  '-G<GDM,C R,C Q,#5?9&5F+GAM;%!+ 0(4 Q0    ( *D\
M*E0S],3[# L  !1E   5              "  9F)  !S9W)Y+3(P,C(P,3 U
M7VQA8BYX;6Q02P$"% ,4    " "I/"I4;&!'(@X'  !O-@  %0
M    @ '8E   <V=R>2TR,#(R,#$P-5]P<F4N>&UL4$L%!@     '  < WP$
' !F<      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
